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and apoptosis caused by these conditions. Transcriptome assessment demonstrates that JUND regulates a
cohort of genes that are commonly dysregulated during β cell dysfunction, including pro-oxidant and pro-
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ABSTRACT 
 
UNRAVELING THE β CELL TRANSLATOME: ELUCIDATION OF AN ERK/HNRNPK/JUND AXIS 
AUSTIN L. GOOD 
DORIS A. STOFFERS, M.D., Ph.D. 
In type 2 diabetes, oxidative stress contributes to the dysfunction and loss of pancreatic β cells. A 
highly conserved feature of the cellular response to stress is the regulation of mRNA translation, 
however, the mechanisms underlying this process in β cells are not fully understood. Here we 
use TRAP-seq to examine changes in the ribosome occupancy of mRNAs during conditions 
associated with β cell dysfunction, leading us to identify a cohort of translationally regulated 
genes with 3’UTR enrichment of a cytosine-rich motif. Of particular interest was the gene 
encoding JUND, a transcription factor with anti-oxidant functions in other cell types but whose 
role in β cells is unknown. Interestingly, JUND is translationally upregulated in islets exposed to 
high glucose and free fatty acid levels, and depletion of JUND in β cells reduces oxidative stress 
and apoptosis caused by these conditions. Transcriptome assessment demonstrates that JUND 
regulates a cohort of genes that are commonly dysregulated during β cell dysfunction, including 
pro-oxidant and pro-inflammatory genes, consistent with this factor enhancing, rather than 
reducing, oxidative stress levels in β cells. Further, hnRNPK, an RNA binding protein with 
specificity for cytosine-rich stretches, binds to the mRNA encoding JUND and is required for its 
post-transcriptional upregulation during metabolic stress. Although the absolute levels of hnRNPK 
do not change, there is a significant increase in hnRNPK phosphorylation during glucolipotoxicity. 
Importantly, this hnRNPK/JUND axis is activated in islets from diabetic db/db mice and in human 
islets exposed to metabolic stress. Finally, a series of mechanistic studies indicate that hnRNPK 
post-transcriptionally regulates JUND in a MEK/ERK- and DDX3X-dependent manner. Thus, a 
translation-centric approach uncovered hnRNPK and JUND as stress-responsive factors in β 
cells that contribute to redox imbalance and apoptosis during pathophysiologically relevant stress. 
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CHAPTER 1: INTRODUCTION 
1.1  Paradigms of β cell demise in type 2 diabetes  
By 2030, it is predicted that 439 million people across the world, or 7.7% of the 
total adult population, will have diabetes (Shaw et al., 2010). The peril posed by 
this global escalation in type 2 diabetes (T2D) prevalence is manifold. First, this 
disease can have debilitating consequences for patients including blindness, 
amputations, and kidney disease. Additionally, the treatment of patients with 
diabetes accounted for at least 1 in 8 US health care dollars in 2017 (American 
Diabetes Association, 2018). Therefore, the identification of new treatment 
strategies to combat the rising prevalence of T2D is a critical task for the 
biomedical research community.  
A key biological determinant of T2D pathogenesis is the functioning of highly 
specialized cells that reside within the pancreas known as pancreatic β cells. 
These are the only cells in the body capable of producing and secreting the 
hormone insulin to regulate blood glucose levels. β cells, along with other 
endocrine cell types, are found within clusters of cells known as islets of 
Langerhans, or islets for short. During the progression of T2D, insulin resistance 
of peripheral tissues, such as the liver, muscle, and adipose, places a growing 
burden on pancreatic β cells to produce and secrete more insulin. Eventually, the 
demand for insulin surpasses the functional capacity of β cells, leading to 
hyperglycemia (Leahy, 2005). Furthermore, this discrepancy worsens as the 
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disease progresses due to a decline in the number and in the functioning of β 
cells. This outcome, known as β cell failure, leads to severe hyperglycemia and 
diabetic complications (Prentki and Nolan, 2006). There are several proposed 
mechanisms to explain the development of β cell failure in T2D, including 
impaired insulin secretion, β cell apoptosis, and loss of β cell identity, termed 
“dedifferentiation” (Figure 1.1) (Kitamura, 2013). However, the relative 
contribution of these processes towards T2D pathogenesis is unclear and may 
be dependent on the severity of the disease and the genetic makeup of the 
individual (Prentki and Nolan, 2006).  
 
Figure 1.1. β cell dysfunction, apoptosis, and loss of cell identity contribute to β failure in 
T2D. 
 
1.1.1  Impaired insulin secretion 
In response to insulin resistance in obese individuals, β cells can augment insulin 
secretion as much as five times that seen in healthy controls despite only a 50% 
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increase in β cell mass (Kahn et al., 2006). This indicates that the insulin 
secretory capacity of a single β cell is dynamic and can be expanded to 
accommodate increased demand. Thus, the ability of β cells to compensate for 
insulin resistance is dependent not just on the number of β cells present in the 
pancreas, but also on the functional capacity of those cells. Indeed, it has been 
suggested that the initial cause of hyperglycemia in T2D is primarily a 
consequence of defects in insulin secretion, not a reduction in the number of β 
cells (Prentki and Nolan, 2006). For example, there is only a very small reduction 
in β cell mass in patients with a 5 year history of T2D, which is unlikely to explain 
the presence of hyperglycemia in the absence of defective insulin secretion 
(Rahier et al., 2008). Similarly, C57BL/6 mice fed a high fat diet for 8 weeks 
develop hyperglycemia, and the severity of the rise in blood glucose levels 
correlates with impairments in insulin secretion, but not β cell mass (Peyot et al., 
2010). 
This notion of β cell dysfunction caused by conditions associated with T2D is  
also supported by experiments performed on cultured islets obtained from mice 
or deceased human organ donors. In this ex vivo paradigm, the concentrations of 
glucose and free fatty acid levels in the culture media can be increased to mimic 
changes that occur in T2D, a model referred to as glucolipotoxicity. Exposure of 
either mouse or human islets to these conditions causes defects in glucose-
stimulated insulin release (Doliba et al., 2017). Together, these findings indicate 
that impaired insulin secretion from β cells contributes to the inadequate insulin 
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levels in patients with T2D, and is especially central during early stages of the 
disease.  
1.1.2  β cell apoptosis 
Although reductions in β cell mass may be unable to fully explain the rises in 
blood glucose levels that occur during early stages of T2D, it is clear that long-
standing cases of T2D and severe hyperglycemia are associated with a 
significant decline in the number of β cells (Rahier et al., 2008). This distinction is 
especially important when considering the likelihood of success for particular 
therapeutic interventions. For example, sulfonylureas, which increase insulin 
release from β cells, may be inadequate to restore normoglycemia if there is a 
significant reduction in β cell mass (Page and Reisman, 2013). 
A main cause of reduced β cell mass in T2D is an increase in β cell apoptosis 
(Prentki and Nolan, 2006). Examination of pancreatic tissue from autopsies 
indicated that individuals with T2D had reduced β cell mass that was associated 
with increased rates of β cell apoptosis (Butler et al., 2003). Many studies have 
also shown that elevations in glucose and/or free fatty acid levels lead to 
increased apoptosis in β cells during ex vivo culturing (Kharroubi et al., 2004; 
Robertson et al., 2003; Shimabukuro et al., 1998). 
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1.1.3  Loss of β cell identify 
Although significant evidence indicates that β cell apoptosis contributes to the 
reduction in β cell mass in T2D, it has recently come into question whether cell 
death can fully explain this decrease in β cell number. An alternative explanation 
has been proposed in which β cells lose their cell identity during the development 
of T2D, which entails the acquisition of features normally restricted to progenitor 
cells or other endocrine cell types (Accili et al., 2016; Dor and Glaser, 2013). This 
model has been considered plausible partly because there is known to be a high 
degree of cellular plasticity amongst endocrine cells of the pancreas (Puri et al., 
2015). For example, after near complete destruction of β cells in mice, α cells 
can convert into β cells to regenerate this population (Thorel et al., 2010).  
This concept of cellular plasticity was first applied to β cell failure based on the 
observation that β cells lose markers of mature β cells and acquire markers of 
progenitor cells in mice with genetic deletion of the transcription factor FOXO1 or 
in murine models of diabetes (Talchai et al., 2012). The relevance of these 
findings to human β cells in T2D, however, is unresolved. A survey of human 
diabetic pancreata at autopsy did not find re-expression of NGN3, a marker of 
endocrine progenitor cells shown to be increased in mouse models with β cell 
dedifferentiation. However, there were some abnormal findings in this analysis 
that could support a loss of β cell identity, including cells with co-expression of 
NKX6.1 and glucagon/somatostatin and the misexpression of ALDH1a3, another 
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progenitor cell marker (Cinti et al., 2015). Therefore, it will be critical to reach a 
consensus on the features that define a “dedifferentiated” β cell to properly 
assess its relevance for T2D. It will also be important to further clarify the fate of 
these cells: have they truly adopted a new cell identity or do they simply 
represent dysfunctional β cells? Regardless, the idea that reduced β cell mass in 
T2D is not solely caused by apoptosis raises the exciting possibility that this loss 
may be reversible. 
1.2  β cell stress in T2D  
In order to develop new therapeutic strategies to prevent or reverse β cell failure 
in T2D, the molecular mechanisms underlying these deleterious processes need 
to be elucidated. For example, what signaling pathways in β cells promote the 
adoption of an apoptotic fate? What factors control β cell identity and how are 
they dysregulated in disease conditions? A common theme that begins to 
address these questions is that β cells endure various forms of cellular stress in 
the pathogenesis of T2D. In this context, the term “stress” refers to a significant 
deviation from a homeostatic set point that causes cellular dysfunction and/or 
damage. In particular, an imbalance in redox homeostasis, or oxidative stress, 
and an imbalance in protein folding homeostasis, or ER stress, have been 
implicated in β cell demise in diabetes. 
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1.2.1  Oxidative stress 
Reactive oxygen species (ROS) are normal byproducts of cellular respiration, 
and the major endogenously produced forms of ROS include hydrogen peroxide, 
superoxide, and hydroxyl radical (Lipinski, 2001). When generated at low levels, 
ROS can function as critical signaling molecules. An important mechanism for 
ROS-mediated signaling involves cysteine residues, which are particularly 
susceptible to oxidation by ROS due to unique properties of their thiol group 
(Poole, 2015). Cysteine oxidation can cause rearrangements in protein 
conformation, leading to changes in function or activation of signaling pathways 
(Ray et al., 2012). For example, oxidation of Cys-2991 of the kinase ATM by 
hydrogen peroxide increases its activity to promote DNA break repair processes 
(Guo et al., 2010). When present at high levels, however, ROS can be very 
detrimental to the cell by damaging lipids, proteins, and DNA, and the onset of 
ROS-mediated injury is referred to as oxidative stress (Schieber and Chandel, 
2014). Lipids within cell membranes are particularly vulnerable to oxidation, 
which can severely disrupt the structure and function of lipid membranes 
throughout the cell leading to cell death (Rochette et al., 2014).   
Oxidative stress is proposed to be a central contributor to β cell failure in T2D. 
Islets from patients with T2D show increased levels of 8-hydroxy-2' –
deoxyguanosine, a marker of oxidative damage to DNA (Del Guerra et al., 2005). 
Animal models of T2D, such as chronic high fat diet feeding in mice, also display 
signs of oxidative damage in β cells (Hatanaka et al., 2017). Furthermore, 
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antioxidant treatment (Han et al., 2015) or overexpression of antioxidant genes 
(Yagishita et al., 2014) can improve β cell function in models of T2D, suggesting 
that oxidative stress is an important determinant of β demise in T2D. 
The development and resolution of oxidative stress depends on the balance 
between the generation of ROS and the levels of antioxidant enzymes that 
detoxify these molecules. Antioxidant genes can be subdivided into three groups 
based on their targeted ROS species and mechanisms of action: superoxide 
dismutases, peroxidases, and thiol-redox proteins (Gelain et al., 2009). 
Antioxidant genes are broadly expressed across tissues due to their essential 
role in preventing oxidative stress, but their relative expression levels can vary to 
meet the needs of a particular cell type. For example, β cells are thought to be 
particularly sensitive to oxidative stress due to low expression levels of 
antioxidant genes (Lenzen et al., 1996). This is especially true for the hydrogen 
peroxide-inactivating enzymes catalase and glutathione peroxidase, which are 
expressed in islets at levels less than 5% of that in the liver (Tiedge et al., 1997). 
The effect of ROS production on β cell homeostasis is complex because it is 
dependent on both the type and subcellular location of the oxidant (Figure 1.2). 
For example, β cells seem particularly vulnerable to cell death caused by 
superoxide and hydrogen peroxide but are mostly resistant to the oxidant 
peroxynitrite, which is generated by the reaction of superoxide with nitric oxide 
(Broniowska et al., 2015). This effect cannot be explained by the potency of 
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oxidation as peroxynitrite is a very strong oxidant (Pacher et al., 2007). Thus, the 
effect of ROS on β cell viability is partly determined by the types of oxidants 
being produced, which is further complicated by the reactivity of these molecules 
with each other. Along these lines, treatment of islets with low levels of hydrogen 
peroxide, but not other oxidants, has been found to increase insulin secretion (Pi 
et al., 2007).  
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Figure 1.2. ROS production from various subcellular locations contributes to the onset of 
oxidative stress. Adapted from (Kreuz and Fischle, 2016).  
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Besides the type of oxidant, the site of ROS production in β cells will also dictate 
its impact on apoptosis and can vary depending on the conditions invoking 
oxidative stress (Figure 1.2). Under conditions of excess glucose, for example, 
increased electron flux through the respiratory chain leads to increased 
production of superoxide in mitochondria (Robertson et al., 2003). Mitochondria 
contain a distinct set of antioxidant enzymes that detoxify ROS produced in this 
setting, such as mitochondrial superoxide dismutase that resides exclusively in 
the mitochondrial matrix (Ježek et al., 2012). Thus, the severity of oxidative 
stress in mitochondria will largely be determined by the functioning of 
mitochondrial, but not cytosolic, antioxidant enzymes. On the other hand, the 
presence of excess lipid can cause fatty acid catabolism to shift largely into 
peroxisomes, which leads to hydrogen peroxide, rather than superoxide, 
generation (Gehrmann et al., 2010). Interestingly, ROS production from 
peroxisomes, rather than mitochondria, has been suggested to promote 
apoptosis in β cells during glucolipotoxicity (Elsner et al., 2010).  
The other major proposed sources of ROS production in β cells are located in the 
cytoplasm. Under conditions of excess glucose, for example, glucose metabolites 
can be shunted towards atypical pathways including the hexosamine pathway, 
which has been suggested to increase hydrogen peroxide levels in β cells 
(Kaneto et al., 2001). Additionally, members of the NADPH oxidase (NOX) family 
can generate cytoplasmic superoxide by directly transferring electrons from 
NADPH to oxygen (Maghzal et al., 2012). These enzymes are best known for 
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their role in innate immunity in which they produce large amounts of superoxide 
in neutrophils for release at sites of infection (Nguyen et al., 2017). NOX-1, -2, 
and -4 are expressed at low levels in β cells, and their activity may be increased 
during exposure to glucotoxicity or pro-inflammatory cytokines (Morgan et al., 
2006; Weaver et al., 2014). Similarly, there are many additional enzymes that 
catalyze redox reactions in common biological processes. For example, the 
metalloreductase STEAP4 facilitates the movement of electrons from NAPDH to 
extracellular iron or copper (Scarl et al., 2017). Under certain conditions, 
however, this enzymatic function of STEAP4 may promote oxidative stress in the 
cell (Zhou et al., 2013a). Thus, ROS production can also be derived from the 
enzymatic activity of pro-oxidant genes. Given the wide range of sources, 
subcellular locations, and types of oxidants produced in the cell, it is not 
surprising that the pertinent causes of oxidative stress in β cells during T2D are 
still uncertain.  
Additionally, the upregulation of antioxidant genes to combat oxidative stress 
may be a coordinated process in the cell. For example, the transcription factor 
NRF2 is a key regulator of antioxidant genes across different cell types (Itoh et 
al., 1997). In the absence of oxidative stress, NRF2 is targeted for ubiquitination 
by the adaptor protein KEAP1 leading to its proteasomal degradation. Increased 
ROS levels, however, inhibit KEAP1 function via cysteine oxidation, and NRF2 
levels accumulate in the nucleus to upregulate antioxidant genes (Uruno and 
Motohashi, 2011). Interestingly, overexpression of NRF2 in β cells improves 
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hyperglycemia in several models of diabetes (Uruno et al., 2013; Yagishita et al., 
2014). Similarly, the transcription factor JUND has also been proposed to reduce 
oxidative stress by regulating antioxidant gene expression (Gerald et al., 2004; 
Paneni et al., 2013). However, its role in β cell redox homeostasis is unknown. 
In all, there is strong evidence linking oxidative stress to β cell dysfunction and 
apoptosis. However, there are many potential mechanisms that may contribute to 
ROS accumulation during T2D pathogenesis and the relative contribution of 
these processes to β cell demise is unclear. Thus, advances in our 
understanding of how β cells adapt to environmental conditions associated with 
oxidative stress may provide new therapeutic opportunities for T2D. 
1.2.2  ER stress 
Another instance of homeostasis that is critical for cell viability is the balance 
between the abundance of nascent peptides and the protein folding capacity of 
the endoplasmic reticulum (ER). If protein synthesis exceeds the folding capacity 
of the ER, there will be an accumulation of unfolded proteins, termed ER stress. 
Prolonged ER stress can lead to protein aggregation, cellular dysfunction, and 
apoptosis (Hetz, 2012). Since a major function of β cells is to synthesize and 
process proinsulin polypeptides, the balance between protein synthesis and 
folding is particularly important in these cells. In T2D, ER homeostasis is 
disrupted when insulin resistance causes the demand for insulin synthesis to 
overwhelm the folding capacity of β cells (Evans Molina et al., 2013).  
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The response to ER stress consists of a highly conserved set of processes 
known as the unfolded protein response (UPR). The presence of unfolded 
proteins in the ER activate three distinct branches of the UPR: IRE1α/XBP1, 
PERK, and ATF6. Together, these factors activate a cellular program that initially 
aims to restore protein folding homeostasis by increasing expression of ER 
chaperones and degrading unfolded proteins (Figure 1.3). Chronic activation of 
the UPR, however, promotes cell death via pro-apoptotic factors, such as CHOP 
(Hetz et al., 2013).  
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Figure 1.3. The unfolded protein response (UPR) shapes cellular adaptation to ER stress. 
Adapted from (Navid and Colbert, 2017). 
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Pancreata from T2D patients show evidence of ER stress in β cells, including 
induction of CHOP and dysregulation of the UPR mediators ATF6 and XBP1 
(Engin et al., 2014; Huang et al., 2007). Mutations in the gene EIF2AK3, which 
encodes PERK, leads to permanent neonatal diabetes due to a reduction in the 
number of β cells (Delépine et al., 2000). Furthermore, culturing islets under 
glucolipotoxic conditions leads to ER stress, UPR activation, and apoptosis 
(Laybutt et al., 2007). On the other hand, genetic deletion of CHOP rescues β 
cell survival and function in several mouse models of T2D (Song et al., 2008). 
Thus, chronic activation of the UPR occurs in β cells during metabolic stress, 
leading to cellular dysfunction and apoptosis.  
Beyond the canonical components of the UPR, β cell-specific factors may also 
shape the ER stress response to fit the particular needs of this cell type. For 
example, the transcription factor PDX1 is required for pancreas organogenesis 
and maintenance of cell identity in mature β cells (Gao et al., 2014; Jonsson et 
al., 1994; Stoffers et al., 1997a), and specific heterozygous mutations in PDX1 
cause monogenic diabetes (Stoffers et al., 1997b). Furthermore, mice with 
heterozygous loss of PDX1 have defects in β cell compensation during high fat 
feeding, which is associated with increased ER stress and apoptosis in β cells. 
PDX1 promotes adaptation to a high fat diet by regulating the expression of 
genes involved in ER function and the UPR (Sachdeva et al., 2009). This 
indicates that PDX1 enhances β cell resiliency during ER stress by shaping an 
adaptive gene regulatory network. 
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This example also serves to illustrate a general principle that deserves further 
elaboration. The identification of PDX1 as a key regulator of β cell adaptation to 
stress implies that a useful approach to better understand the mechanisms 
underlying the stress response in β cells is to closely scrutinize the network of 
genes that become dysregulated upon depletion of PDX1. This approach holds 
promise to advance our understanding of how β cells adapt to stress, how this 
adaptation may fail in disease, and what targets may be candidates for 
therapeutic intervention.  
1.3  Translational regulation and cellular stress 
A critical and prominent part of stress responses across cell types is the 
regulation of mRNA translation, which allows for rapid changes in gene 
expression to restore homeostasis. For example, one component of the UPR is 
increased translation of the mRNA encoding ATF4, a transcription factor that 
upregulates genes involved in protein folding (Harding et al., 2000; Lu et al., 
2004). Further, genome-wide assessment of ribosome occupancy, a proxy for 
translational efficiency, shows a striking reprogramming of translation for 
hundreds of genes during ER stress and heat shock (Sidrauski et al., 2015; 
Ventoso et al., 2012; Zhou et al., 2015). Since translational regulation may not be 
accompanied by changes in mRNA abundance, common approaches such as 
RNA-seq will not detect this layer of gene regulation. As such, translational 
regulation represents an essential, yet understudied, mechanism of cellular 
adaptation during stress. 
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β cells are highly secretory cells that require tight control of protein synthesis for 
proper functioning (Evans Molina et al., 2013; Scheuner et al., 2005). For 
example, the acute adaptation to high levels of glucose includes increased 
translation of the mRNA encoding proinsulin (Itoh and Okamoto, 1980). 
Furthermore, excess translation rates during glucolipotoxicity have been linked to 
the onset of ER stress (Hatanaka et al., 2014). However, the mechanisms 
underlying translational regulation in β cells during stress conditions are poorly 
understood. 
1.3.1  Overview of translation initiation  
Translation initiation consists of a highly regulated, multi-step process that is 
generally considered the rate-limiting step of translation (Parsyan et al., 2011), 
although regulation can occur at the level of translation elongation in some 
circumstances (Hussey et al., 2011). The process of translation initiation requires 
recruitment of the 43S pre-initiation complex (PIC) to the 5’ end of the mRNA, 
scanning of the PIC to a start codon, and formation of a competent ribosomal 
complex for elongation (Figure 1.2). For most mRNAs, this process is dependent 
on the presence of two particular RNA modifications that are added post-
transcriptionally: a 7-methylguanylate (m7G) cap at the 5’ end and a stretch of 
adenosine monophosphates at the 3’ end (poly(A) tail). Upon export to the 
cytoplasm, mRNA is bound at the 5’ cap by the eukaryotic translation initiation 
factor 4E (eIF4E), which is part of a heterotrimeric complex called eIF4F that also 
includes a scaffold protein eIF4G and an RNA helicase eIF4A. Separately, the 
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small ribosomal subunit (40S) is decorated by many additional translation 
initiation factors, including eIF2, the initiator tRNA, and the multi-subunit factor 
eIF3, and this large complex is collectively called the 43S PIC. Interaction 
between eIF4G and eIF3 facilitates the recruitment of the 43S PIC to the mRNA 
5’ cap, after which the 43S PIC scans along the mRNA until a start codon is 
encountered. This is followed by the assembly of an 80S ribosomal complex, 
which requires GTP hydrolysis by eIF2 and recruitment of the 60S ribosomal 
subunit (Jackson et al., 2010).  
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Figure 1.4. Translation initiation is a complex, multi-step process. Adapted from (Parsyan 
et al., 2011). 
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In addition to the assembly of translation machinery at the 5’ end of mRNAs, 
efficient translation also depends upon factors binding to the 3’ end, most 
importantly the poly(A)-binding protein (PABP). This factor binds to the poly(A) 
tail and eIF4G to facilitate RNA circularization. These interactions are thought to 
increase the efficiency of translation by enhancing binding of eIF4F to the 5’ cap 
and facilitating the re-initiation of ribosomal subunits at start codons after 
termination, termed ribosome recycling (Dever and Green, 2012).  
While these steps encompass translation initiation for most mRNAs, certain 
properties can alter the requirements for initiation to occur. For example, some 
mRNAs contain a highly structured 5’ UTR that inhibits scanning of the PIC. In 
this case, efficient translation initiation requires supplementary factors, such as 
additional RNA helicases, to unwind the RNA secondary structures and promote 
scanning (Marintchev, 2013). Besides providing structural blockades for 
translation, RNA secondary structure in 5’ UTRs can also influence the function 
of initiation factors. For example, eIF3 generally promotes translation initiation via 
recruitment of the PIC, however, certain mRNAs contain 5’ UTR structural 
elements that cause eIF3 to act as a translational repressor (Lee et al., 2015).  
A useful paradigm for studying atypical modes of translation initiation is the 
translation of viral mRNAs. Viruses are completely dependent on the host 
translation machinery for their replication and propagation. Counterintuitively, 
however, many viruses incapacitate the translation machinery of infected cells to 
shut-off translation of host mRNAs. This is achieved by a broad range of 
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mechanisms, including expression of a viral protease that cleaves eIF4G 
(poliovirus), reducing eIF4E expression levels (enterovirus 71), sequestration of 
eIF3 via viral proteins (measles virus), and cleavage of PABP by viral proteases 
(retroviruses) (Walsh et al., 2013). While this impairment of translation cripples 
the host’s defense mechanisms, it also presents the conundrum of how to 
translate viral mRNAs. For this reason, viruses have evolved various 
mechanisms to initiate translation using host machinery in a cap-independent 
manner. One prominent example of this phenomenon is the presence of an 
internal ribosomal entry site (IRES) near the 5’ end of viral mRNAs. IRESs are 
highly structured RNA elements that recruit the 40S ribosomal subunit to mRNA 
in a cap-independent manner. There are several different classes of IRESs, each 
of which require a distinct subset of trans-acting factors, including translation 
initiation factors, RNA binding proteins, and viral proteins, for efficient translation 
(Sweeney et al., 2013). For example, the IRES in poliovirus mRNA requires 
eIF4F and eIF3 for recruitment of the 40S ribosomal subunit, whereas hepatitis C 
virus mRNA requires eIF3 but not eIF4F and cricket paralysis virus mRNA does 
not require either of these factors (Komar et al., 2012). Importantly, many of 
these mechanisms for alternative initiation are thought to be pirated from their 
hosts, meaning that certain host mRNAs also employ these mechanisms under 
certain conditions. For example, the mRNA encoding c-MYC contains an IRES 
element, which confers cap-independent translation that is stimulated by the 
RNA binding protein hnRNPK (Evans et al., 2003). The broad range of 
mechanisms employed by viruses for translation initiation raises the intriguing 
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possibility that we have only just begun to understand the usage of these 
processes for translational regulation of endogenous mRNAs. 
Indeed, the multi-faceted process of translation initiation is regulated at various 
steps during stress conditions, allowing for the tight control of both global 
translation rates and selective translation of key mRNAs. Below, we outline 
several examples of translational regulation during stress that influence cellular 
homeostasis.  
1.3.2  Regulation of global translation rates 
Protein synthesis consumes a significant amount of cellular energy, thus 
dampening global translation rates during stress conserves cellular resources 
and promotes cell survival (Evans Molina et al., 2013). For example, the UPR 
influences global translation rates by several mechanisms. First, activated PERK 
phosphorylates eIF2α, which reduces its function and suppresses translation 
initiation (Hetz, 2012). This regulation is critical for β cell adaptation to stress in 
vivo as mutation of the phosphorylated site of eIF2α in mice led to the 
accumulation of unfolded proteins and defective insulin secretion during high fat 
feeding (Scheuner et al., 2005). Second, 4E-BP1, which reduces global 
translation rates by sequestering eIF4E, is upregulated by ATF4 and ATF5 
during ER stress (Juliana et al., 2017; Pause et al., 1994; Spriggs et al., 2010). 
Loss of 4E-BP1 in β cells leads to increased apoptosis during conditions of ER 
stress due to unchecked translation rates (Yamaguchi et al., 2008). Thus, 
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dampening translation is critical for the adaptation of β cells to ER stress 
because it reduces the protein folding burden and conserves cellular resources.  
While we have highlighted the importance of regulating general protein synthesis 
during stress, it should be noted that control of this process is also essential for 
cell growth. For example, the mTOR signaling pathway integrates growth signals 
with downstream processes required for proliferation, including cap-dependent 
translation. Specifically, mTOR increases global translation rates by activation of 
the ribosomal protein S6K and inactivation of 4E-BPs, thereby increasing the 
availability of eIF4E for translation initiation (Mamane et al., 2006). This increase 
in translation allows for the synthesis of proteins to accommodate the expansion 
of cell size and the formation of new cells.	  
1.3.3  Selective regulation of translation  
While the regulation of global translation rates promotes recovery from stress by 
conserving cellular resources and reducing the protein folding burden, the 
selective translation of mRNAs impacts cellular homeostasis indirectly by altering 
the gene expression program of the cell. This mechanism for altering gene 
expression may be advantageous over transcriptional regulation because it 
occurs downstream of transcription and thus can very quickly alter protein levels 
(Sidrauski et al., 2015).  
In order for selective translation to occur, this directive must be encoded in the 
mRNA, which can be achieved by three general mechanisms. First, selective 
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translation can be governed by the presence of regulatory sequences in the 
mRNA that are bound by sequence-specific factors that regulate translation, such 
as RNA binding proteins (RBPs) or microRNAs. Second, mRNAs can be 
translationally regulated based on the presence of RNA secondary structures 
rather than primary sequence elements. Lastly, upstream open reading frames 
(uORFs) in 5’UTRs can affect the re-assembly of ribosome complexes on 
downstream canonical initiation codons (Jackson et al., 2010). The translational 
induction of genes containing uORFs, such as ATF4, ATF5, and CHOP, has 
been well characterized to be a consequence of eIF2α phosphorylation by PERK 
during ER stress (Somers et al., 2013). However, the extent to which primary 
sequence or secondary structural elements shape translational regulation during 
stress is less known. 
Importantly, these regulatory elements may be present in a cohort of genes that 
are functionally related, allowing for the coordinated re-shaping of gene 
expression towards a specific purpose. This notion forms the basis of the “RNA-
operon” theory, which postulates that trans-acting factors, such as RBPs, may 
integrate environmental signals with the post-transcriptional regulation of specific 
genes that share a common function (Keene, 2007). This model is especially 
intriguing in the context of β cell adaptation to pathophysiologically-relevant 
conditions; however, the role of RBPs in shaping the β cell gene expression 
program in response to external cues is largely unknown.  
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RBPs regulate all aspects of post-transcriptional RNA processing, including 
splicing, stability, localization, and translation. In fact, mRNAs are generally 
bound by a broad array of RBPs throughout their life cycle, positioning these 
factors to rapidly integrate cellular signals with changes in gene expression. The 
target specificity of an RBP is directed by its RNA-binding domain, which 
interacts with RNA in a sequence- and structure-dependent manner (Lukong et 
al., 2008). It is estimated that there are anywhere between 500 and 1500 RBPs 
in humans containing more than 40 different types of RNA-binding domains, 
underscoring the broad importance of these proteins in biological processes 
(Gerstberger et al., 2014). For example, the most common RNA-binding domain, 
the RNA recognition motif (RRM), is found in more than half of all RBPs and is a 
highly plastic domain that can bind RNA with both high-affinity and high-
specificity (Maris et al., 2005).  
RBP-mediated post-transcriptional regulation is exemplified in β cells by the role 
of the polypyrimidine tract-binding protein (PTB) in adaptation to hyperglycemia. 
Part of the β cell response to high glucose levels is the upregulation of genes 
involved in insulin processing and secretory granule biogenesis, and many of 
these genes were found to be upregulated at the level of mRNA stability, not 
transcription (Knoch et al., 2004; Martin et al., 1994). Interestingly, loss of PTB 
blocked the post-transcriptional induction of these genes and significantly 
reduced insulin granule biogenesis (Knoch et al., 2004). Thus, by coordinating 
the post-transcriptional regulation of genes with a common function, constituting 
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an RNA operon, PTB augments β cell insulin secretory capacity during high 
glucose conditions. It is enticing to speculate that this example is just the tip of 
the iceberg for RBPs mediating adaptive mechanisms in β cell. Therefore, a 
systematic evaluation of post-transcriptional changes in β cells, and the RBPs 
governing these changes, warrants close examination.  
1.3.4  Translational regulation mediated by the PCBPs  
The poly(C)-binding protein (PCBP) family consists of five members: hnRNPK 
and PCBP1-4. These factors all contain three K homology (KH) domains, which 
provide the specific targeting of cytosine-rich sequences (Makeyev and 
Liebhaber, 2002). The PCBP members are highly multifunctional RBPs involved 
in many aspects of gene regulation, including transcription, splicing, alternative 
polyadenylation, mRNA stability, and translation (Bomsztyk et al., 2004; Ji et al., 
2013; 2016; Makeyev and Liebhaber, 2002; Ostareck-Lederer et al., 2002; 
Waggoner et al., 2009). Their impact on gene expression is likely determined by 
a host of factors, including their subcellular localization, post-translational 
modifications, and interacting co-factors (Bomsztyk et al., 2004). The members 
hnRNPK and PCBP1-2 are ubiquitously expressed and play critical roles in a 
range of cellular processes, some of which are cell type-specific (Makeyev and 
Liebhaber, 2002). For example, PCBP1-2 promote the differentiation of functional 
erythrocytes by binding to the 3’UTR of α-globin mRNA and significantly 
stabilizing this transcript (Kiledjian et al., 1995). These factors are also regulated 
extensively by post-translational modifications, especially phosphorylation. This 
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allows for the function of these proteins, including their impact on mRNA 
translation, to be modulated downstream of various signaling pathways 
(Chaudhury et al., 2010a).  
The first example of translational regulation mediated by the PCBPs was the 
translational silencing of the mRNA encoding erythroid 15-lipoxygenase. This 
enzyme is responsible for the breakdown of phospholipids during late stages of 
erythrocyte maturation and must be silenced at earlier stages. Interestingly, 15-
lipoxygenase mRNA is abundantly expressed throughout the stages of 
differentiation. Rather, its temporally restricted expression pattern is entirely 
dependent on translational silencing via a large cytosine-rich stretch in the 3’ 
UTR. hnRNPK and PCBP1 were identified as the factors binding to this 
regulatory element and inhibiting translation by preventing 60S ribosomal subunit 
joining (Ostareck et al., 2001; 1997). Curiously, translation of the mRNA 
encoding c-Src kinase is also translationally silenced in erythroid progenitor cells 
by hnRNPK, but not PCBP1 (Naarmann et al., 2008). Thus, three different 
mRNAs expressed in erythroid cells, 15-lipoxygenase, c-Src, and α-globin, are 
post-transcriptionally regulated by members of the PCBP family via binding to C-
rich sequences in the 3’UTR. Despite these similarities, the regulation of these 
mRNAs are distinct based on the mode of regulation (RNA stability or translation) 
and on the PCBP family members imparting this regulation. It is unclear how 
these RBPs provide distinct functions depending on their target mRNA but likely 
depends on the presence of additional cofactors. 
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Along these lines, the translational regulation provided by PCBP family members 
can be either translational enhancement or repression. Like 15-lipoxygenase and 
c-Src, hnRNPK represses translation of the mRNAs encoding transforming 
growth factor-β-activated kinase 1 (TAK1) and the androgen receptor (Liepelt et 
al., 2014; Mukhopadhyay et al., 2009). On the other hand, hnRNPK has been 
implicated in the translational enhancement of the mRNAs encoding Bruton’s 
tyrosine kinase (p65BTK), myelin basic protein (MBP), neurofilament medium 
(NF-M), vascular endothelial growth factor (VEGF), and c-MYC (Evans et al., 
2003; Grassilli et al., 2016; Hutchins and Szaro, 2013; Laursen et al., 2011; 
Sataranatarajan et al., 2008). PCBP1 and PCBP2 have also been found to either 
stimulate or repress translation depending on the target mRNA (Chaudhury et al., 
2010b; Eiring et al., 2010; Evans et al., 2003; Laursen et al., 2011; Wang et al., 
2010).  
Furthermore, translational regulation mediated by the PCBPs can be modified by 
phosphorylation of these RBPs in response to external cues. For example, the 
mRNAs encoding DAB2 and ILEI, which are critical for epithelial-mesenchymal 
transdifferentiation (EMT), are translationally repressed by PCBP1 via 3’UTR 
binding. Treatment of cells with TGF-β, however, leads to PCBP1 
phosphorylation, reduced PCBP1 binding to the 3’UTRs, and enhanced 
translation of DAB2 and ILEI to promote EMT (Chaudhury et al., 2010b). 
Similarly, phosphorylation of hnRNPK can lead to changes in its subcellular 
localization and RNA binding affinity, both of which can impact target mRNA 
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translation (Habelhah et al., 2001; Ostareck-Lederer et al., 2002; Ostrowski et al., 
2001). hnRNPK likely impacts translation by interacting with cofactors that either 
repress or promote translation initiation (Bomsztyk et al., 2004), and these 
interactions may also be modulated by phosphorylation. For example, 
phosphorylation of hnRNPK by JNK leads to enhanced translation of cytoskeletal 
RNAs required for axon outgrowth in developing neurons of Xenopus laevis. This 
effect on hnRNPK was not attributable to a change in its subcellular localization 
nor a change in its RNA binding affinity. Instead, it was suggested that JNK 
signaling altered the interaction of hnRNPK with translation machinery, however, 
the precise mechanisms by which this occurred were not elucidated (Hutchins 
and Szaro, 2013). 
In the work described herein, we investigate translational regulation and the 
mechanisms controlling these processes in the context of β cell dysfunction. We 
explore the role of the PCBPs in β cells, including their post-transcriptional 
control of gene expression during stress conditions. Together, these studies aim 
to uncover novel mechanisms governing β cell adaptation to stress that may 
pertain to the pathogenesis of T2D. 
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CHAPTER 2: TRAP-SEQ UNCOVERS POST-TRANSCRIPTIONAL 
REGULATION MEDIATED BY THE PCBPS IN β CELLS  
2.1  Summary 
Translational regulation is a highly conserved and critical component of stress 
responses, however, the mechanisms underlying this process in β cells are not 
fully understood. Here we used TRAP-seq to uncover a subset of genes with 
changes in ribosome occupancy in Min6 cells with PDX1 deficiency, including 
genes encoding the transcription factors NKX2-2 and JUND. De novo motif 
analysis identified enrichment of a poly(C) motif in the 3’UTRs of genes with 
increased ribosome occupancy, suggesting a functional role for the poly(C)-
binding protein (PCBP) family of RNA binding proteins in β cells. The PCBP 
members PCBP1, PCBP2, and hnRNPK all bound to the mRNAs encoding 
NKX2-2 and JUND, and loss of PCBP1/2 led to a post-transcriptional reduction in 
these genes. Additionally, glucose-stimulated insulin secretion was impaired in 
Min6 cells with depletion of PCBP1/2 or hnRNPK, suggesting that these factors 
are functionally important in β cells. 
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2.2  Introduction 
The specialization of cells is bestowed largely by the distinct catalog of proteins 
present in a given cell type, yet all cells of an organism contain the same genetic 
information. Thus, mechanisms to selectively decode genetic information are 
crucial for the functional specificity of cells. Advances in our understanding of the 
cellular controls that decode genetic information, and how they become 
dysfunctional in disease states, will be a central step towards unlocking the next 
generation of medical therapeutics. For example, we are on the cusp of treating 
an array of diseases with cell-based therapies. The advancement and expansion 
of these approaches, however, will rely on a better understanding of the genetic 
controls shaping cell identity and how environmental cues impact these 
processes. 
The decoding of genetic information for the synthesis of proteins is dynamic and 
requires a full cycle of events to take place: transcription of DNA into RNA, 
processing RNA to mRNA, translation of mRNA to protein, and degradation of 
mRNA/protein. Importantly, all of these steps represent potential regulatory 
points to shape the gene expression profile of a cell. Due to rapid advances in 
the depth and accuracy of DNA sequencing technologies, however, it is 
commonplace to use mRNA abundance as a proxy for the functional output of 
genetic information. This approach is certainly useful when focusing on 
transcriptional regulators, but it will miss regulation at the level of mRNA 
translation or protein degradation. This has led to a bias in our understanding of 
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gene regulation, including in β cells: the factors shaping transcriptional regulation 
are much better understood than those regulating mRNA translation. 
Translational regulation is particularly important in the context of dynamic shifts in 
gene expression required for adaptation to environmental conditions, external 
stimuli, or stress conditions. Since translation is downstream of transcription, a 
cell can respond to a stimulus more quickly by increasing translation of an mRNA 
compared to increasing its transcription. The regulation of translation can be 
grouped into two broad categories: regulation of global translation rates and 
selective translational regulation of specific mRNAs. Tight control of global 
translation rates is critical for cells because protein synthesis is associated with 
high cellular energy consumption. A common mechanism for this type of 
translational regulation is post-translational modification of a component of the 
translation machinery. For example, mTOR signaling integrates growth signals 
with translation rates by phosphorylating eukaryotic translation initiation factor 
4E-binding protein 1 (4E-BP1) and ribosomal protein S6K1/2 (Mamane et al., 
2006).  
Selective regulation of translation, on the other hand, allows for rapid changes in 
gene regulatory networks that shape the cellular response to various conditions.  
This mechanism for translational regulation seems to be particularly important in 
the context of cellular stress responses. For example, during ER stress there is 
increased translation of select mRNAs with upstream open reading frames 
(uORFs), such as ATF4. This response promotes restoration of ER homeostasis 
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by increasing the protein folding capacity of the ER (Harding et al., 2000). 
Similarly, inhibition of cap-dependent translation occurs under various stress 
conditions, such as during infection of cells with picornaviruses due to cleavage 
of eIF4G by a viral protease or during ER stress due to upregulation of 4E-BP1. 
These alterations of translational machinery promote the cap-independent 
translation of specific mRNAs containing internal ribosomal entry sites (IRESs) 
while global translation rates are suppressed (Spriggs et al., 2008). For example, 
the transcript encoding the chaperone BiP was the first eukaryotic mRNA found 
to contain an IRES, which allows for the translation of this factor during ER stress 
to enhance cellular protein folding capacity (Macejak and Sarnow, 1991). 
Translation rates of mRNAs can be directly measured by pulse labeling followed 
by mass spectrometry, however, this approach is technically challenging and 
requires large amounts of input material. Accordingly, alternatives to this method 
have been developed that determine the relative density of ribosomes bound to 
mRNAs, which can be assessed on a genome-wide scale with RNA-seq (Kapeli 
and Yeo, 2012). The use of these approaches to assess translational regulation, 
however, relies on several assumptions because they are indirect measurements 
of translation. Nevertheless, an understanding of these assumptions and careful 
scrutiny of the obtained results will allow for the successful implementation of 
these methodologies. For example, an increase in ribosome binding to an mRNA 
cannot distinguish between actively translating or stalled ribosomes. As such, an 
observed change in mRNA ribosome occupancy should be confirmed to cause 
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an appropriate change in protein level by western blot analysis. Additionally, 
ribosome run-off assays can be used to rule out the presence of stalled 
ribosomes (Pelechano et al., 2015). It should also be noted that these 
methodologies are useful for detecting changes in translation initiation, which is 
thought to be the major regulatory step of translation, but not for changes in 
translation elongation or termination. Instead, the study of translational regulation 
occurring at the elongation step requires specific methodologies to assess the 
kinetics of ribosome run-off (Richter and Coller, 2015). 
The first methodology that used changes in ribosome occupancy to assess 
translation was polysome profiling. This method separates mRNAs into different 
fractions based on the relative abundance of bound ribosomes using sucrose 
gradient sedimentation. For example, during ER stress, the mRNA encoding 
ATF4 shifts towards greater representation in the polysome fraction compared to 
the monosome fraction, which indicates an increase in ribosome binding during 
stress (Hatanaka et al., 2014). However, this methodology has several 
disadvantages including the requirement for significant starting material and the 
inability to distinguish between cell types in a heterogeneous tissue. 
Furthermore, this method uses density gradient centrifugation to separate 
mRNAs into polysome and monosome populations. This assumes that the main 
factor contributing to the density of an mRNA is the number of bound ribosomes. 
It is unclear if this assumption is a valid one or if large RNP complexes other than 
ribosomes may contribute to mRNA density (Kuersten et al., 2013). 
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To circumvent some of these disadvantages, methods that rely on the 
immunoprecipitation of tagged ribosomal subunits have also been developed, 
such as Translating Ribosome Affinity Purification (TRAP, GFP-tagged RPL10a) 
and RiboTag (HA-tagged RPL22) (Heiman et al., 2008; Sanz et al., 2009). In 
these methods, comparison of transcript abundance in the immunoprecipitated 
RNA fraction to that in total RNA can be used to determine the ribosome 
occupancy of mRNAs, an approximation of translational efficiency. By expressing 
these transgenes from a cell type-specific promoter, ribosome-bound mRNA can 
be purified for a specific subpopulation of cells within a heterogeneous tissue. 
Therefore, these approaches are particularly useful when attempting to assess 
translational regulation in vivo because most tissues are composed of a complex 
mixture of cell types. Also, these methods use a highly specific 
immunoprecipitation step to purify ribosomes and their associated mRNAs and 
do not rely on the assumption that ribosomes are the main determinant of mRNA 
density.  
One disadvantage to all of the methodologies mentioned above is that they 
involve sequencing of full-length mRNA. For this reason, the positioning of 
ribosomes along mRNAs cannot be discerned by these approaches. In contrast, 
ribosome profiling, which is the most recent advance in studying translation, 
utilizes an RNase digestion step to generate ribosome-protected RNA fragments. 
High-throughput sequencing of these footprints can then be used to determine 
not only the density of ribosomes binding to an mRNA, but also the location of 
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ribosomes along the transcript, including the relative usage of start codons 
(Ingolia et al., 2009; 2011). This allows for the study of alternative translation 
initiation, which is particularly interesting given that initiation from non-AUG 
codons may be a common mechanism to increase protein diversity and can be 
regulated under stress conditions (Touriol et al., 2012).  
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2.3  Materials and Methods 
Cell line culture 
Min6 mouse insulinoma cells passage 20-30 were cultured in high glucose 
DMEM as described (Claiborn et al., 2010), unless otherwise noted. For siRNA-
mediated depletion of Pdx1, cells were nucleofected by AMAXA with siRNA for 
Pdx1 (Dharmacon L-040402-01) or non-targeting control (Dharmacon D-001810-
10) and collected 72hrs post-transfection. For lentiviral infections, Min6 cells 
were transduced for 6 hours with virus and polybrene (Sigma) at 8ug/mL. Cells 
were allowed to recover for 4-5 days before collection or stress treatments. 
HEK293T cells were cultured in DMEM containing 25mM glucose. 
GFP-RPL10A Min6 stable cell line 
The GFP-RPL10A transgene was generated by cloning PCR amplified fragments 
for GFP-RPL10A or GFP into the pBABE-puro retroviral vector (Morgenstern and 
Land, 1990) digested with SalI. Retrovirus was produced in HEK293T cells and 
added to Min6 cells, followed by two rounds of puromycin selection (5 days, 
2ug/mL).  
Glucose-stimulated insulin secretion in Min6 cells 
Min6 cells were seeded in a 12 well plate 3 days prior to GSIS experiment 
(~400,000 cells/well). On day of experiment, fresh KRBH buffer (15mM HEPES, 
120mM NaCl, 4.7mM KCl, 1.2mM MgSO4, 1.2mM KH2PO4, 20mM NaHCO3, 
2mM CaCl2, 0.01% BSA) was prepared and the pH was adjusted to 7.4. Glucose 
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was dissolved in KRBH to obtain solutions with glucose concentrations of 2.5mM 
(low glucose) and 25mM (high glucose). 
Wells were washed with PBS and KRBH (no glucose). 500ul of glucose-free 
KRBH was added to each well and plates were incubated for 1 hour at 37C. 
Wells were washed once with glucose-free KRBH and 500ul of 2.5mM glucose 
KRBH was added to each well, then incubated at 37C for 30 minutes. 100ul of 
supernatant was transferred to tubes and placed on ice. The remaining KRBH 
was removed from each well and one wash with glucose-free KRBH was 
performed. 500ul of 25mM glucose KRBH was added to each well, then 
incubated at 37C for 30 minutes. 100ul of supernatant was transferred to tubes 
and placed on ice. The remaining KRBH was removed, wells were washed twice 
with cold PBS, and cells were harvested with 100ul lysis buffer containing 
protease inhibitor. LG and HG supernatant samples were centrifuged at 1500g 
for 5 min at 4C. 50ul of supernatant was taken and froze at -20C along with cell 
lysates. Insulin levels in LG, HG, and cell lysate samples were measured by 
ELISA (ALPCO, 80-INSMSU-E01), as per manufacturer instructions.   
RNA isolation and RT-qPCR 
For Min6, cells were washed 2X with cold PBS before addition of TRIZOL 
(Invitrogen) and RNA was extracted according to manufacturer’s instructions. 
RNA was reverse transcribed with random hexamers using High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems). Quantitative PCR (BioRad 
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CFX384) was used to measure transcript abundance and normalized to HPRT. 
See Table 1 for a list of primer sequences used for these analyses. 
Western blot 
Proteins were separated by SDS-PAGE and immunoblotted with the following 
antibodies: mouse anti-NKX2-2 (Hybridoma Bank, 74.5A5), rabbit anti-JUND 
(Santa Cruz, sc-74), rabbit anti-PCBP1 (Liebhaber lab), rabbit anti-PCBP2 
(Liebhaber lab), rabbit anti-hnRNPK (Bethyl Laboratories, A300-674A), mouse 
anti-Tubulin (Sigma, T9026), mouse anti-Ran (B.D. 610340), goat anti-GFP 
(Abcam, 6673), mouse anti-RPL10A (Novus, 3G2), rabbit anti-RPL7 (Novus, 
NB100-2269), and rabbit anti-RPS6 (Abcam, ab40820). 
Co-immunoprecipitation 
Min6 cells were lysed in buffer containing 20mM Tris pH 8.0, 137 mM NaCl, 1mM 
MgCl2, 1mM CaCl2, 1% NP-40, 10% glycerol, protease inhibitor cocktail 
(Millipore), and Benzonase (Sigma) at 12.5 U/mL. Lysates were rotated at 4°C 
for 1 hour. Protein concentration was determined using a Micro BCA Protein 
Assay Kit (Thermo). 1ug of primary antibody was added to lysate encompassing 
500ug of protein and incubated overnight at 4°C.  Protein A Dynabeads were 
washed 3 times in lysis buffer then resuspended in lysate/antibody mixture and 
incubated for 3 hours at 4°C. The immunoprecipitations were washed 4 times 
with lysis buffer then eluted in NuPAGE LDS Sample Buffer (Invitrogen) by 
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heating at 70°C for 10 minutes. Eluted proteins and input samples were analyzed 
by western blot. 
TRAP 
TRAP was performed as described (Heiman et al., 2008), with minor 
modifications. Briefly, after stress treatments of GFP-RPL10A Min6 cells, 
cycloheximide (Sigma) was added to the culture media at 100ug/mL for 10 
minutes prior to washing 2X with cold PBS. Cells were lysed and protein 
concentration was measured by BCA (Thermo). Total RNA was isolated (1-5% 
input) with the RNeasy Mini Kit (Qiagen). For IP RNA, cell lysates encompassing 
200ug of protein were added to Protein G Dynabeads bound to GFP antibodies 
(19C8 and 19F7, Memorial Sloan-Kettering Monoclonal Antibody Facility) and 
incubated overnight at 4°C. The next day, the beads were washed 4X with high 
salt buffer, as described8. IP RNA was eluted from beads in RLT buffer and 
extracted using the RNeasy Mini Kit. Ribosome occupancy was determined by 
dividing transcript abundance for each gene in the IP RNA fraction by its level in 
the Total RNA fraction. For TRAP followed by RT-qPCR, RNA was reverse 
transcribed with random hexamers and Superscript III (Invitrogen) and transcript 
abundance was first normalized to HPRT for each fraction before determining 
ribosome occupancy. 
RNA immunoprecipitation 
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RNA immunoprecipitation was performed using rabbit anti-hnRNPK (Bethyl 
Laboratories, A300-674A) or rabbit anti-PCBP1/2 antibodies (Liebhaber lab). 
Antibodies or IgG were bound to Protein A Dynabeads in buffer containing 20mM 
HEPES pH 7.4, 5mM MgCl2, 150mM KCl, 2mM DTT, 1% NP-40. Min6 cells were 
lysed in buffer containing 50mM Tris pH 8.0, 150mM NaCl, and 1% NP-40 with 
RNase, protease, and phosphatase inhibitors. Total RNA was extracted from 
lysate (10% input) using RNeasy Mini Kit (Qiagen). Lysate encompassing 75ug 
of protein was added to beads bound to antibody for hnRNPK or PCBP1/2 and 
an IgG control, then incubated overnight at 4°C. The next day, IPs were washed 
with buffer containing 20mM HEPES pH 7.4, 5mM MgCl2, 350mM KCl, 2mM 
DTT, 1% NP-40, and RNase inhibitors. RNA was eluted from beads in RLT buffer 
(Qiagen) and RNA was isolated using RNeasy Mini Kit (Qiagen). For RIP 
followed by RT-qPCR, enrichment was calculated by first normalizing transcript 
abundance in IP RNA to that in total RNA and then to the IgG control. 
CRISPR design and cloning 
CRISPR gRNAs were designed using http://crispr.mit.edu/ to minimize off-target 
binding (ROSA26: AAGATGGGCGGGAGTCTTCT, hnRNPK:	  
GTTTAATACTTACGTCTGTA, PCBP1: TCGGCTGCTGATGCACGGAA, 
PCBP2: GACACCGGTGTGATTGAAGG). gRNAs were cloned into 
lentiCRISPRv2, as described (Sanjana et al., 2014). 
RNA-seq and analysis 
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RNA was isolated using the RNeasy Mini Kit (Qiagen). Libraries were prepared 
using NEB Next Ultra RNA Library Prep Kit according to manufacturer’s 
instructions with polyA enrichment followed by paired-end sequencing of 150bp 
using HiSeq (Illumina). Reads were mapped to mm10 using TopHat2 (Kim et al., 
2013) and read counts per gene were determined using featureCounts (Liao et 
al., 2014). For TRAP-seq analysis, ribosome occupancy was calculated by 
dividing normalized gene counts in the IP RNA samples by that in the total RNA 
samples. Differential expression analysis was performed using edgeR (Robinson 
et al., 2010) with significant genes called using fold-change cutoffs of greater 
than 1.5 or less than -1.5 and FDR less than 0.05. Gene ontology analysis was 
performed using DAVID (Huang et al., 2009). For RIP-seq analysis, edgeR was 
used to determine enrichment in the hnRNPK immunoprecipitated RNA 
compared to total RNA with significant genes called using a fold-change cutoff of 
greater than 1.5 and FDR less than 1x10-4. An IgG control was performed but not 
sequenced because no RNA was detected in the pull-down by Qubit RNA High 
Sensitivity quantitation. The overlap between RNA-seq data sets was determined 
using hypergeometric tests.  
Statistics 
Data are presented as mean ± standard error of the mean unless otherwise 
noted in figure legends. Statistical analyses were performed using GraphPad 
PRISM 7 software. Statistical tests used are noted in figure legends and include 
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unpaired two-tailed Student’s t-test, one-way analysis of variance (ANOVA), two-
way ANOVA, and hypergeometric test.  
Motif analysis 
De novo motif discovery was performed using the MEME software suite (Bailey 
et al., 2009) with the following parameters: strand-specific search, motif width 4-
10. For motif frequency comparison, control sets of genes were generated by 
randomly selecting 100 genes 10 times from a list of genes with detectable 
expression in Min6 cells but not meeting the criteria for differential ribosome 
occupancy with PDX1 deficiency. The FIMO tool of the MEME suite (Bailey et al., 
2009) was used to determine motif frequencies. The Tomtom tool of the MEME 
suite (Bailey et al., 2009) was used to compare discovered motifs to a database 
of motifs recognized by RBPs (Ray et al., 2014).  
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Gene Name Forward primer Reverse primer 
HPRT TGCTCGAGATGTCATGAAGGA CCAGCAGGTCAGCAAAGAACT 
Beta_actin gctacagcttcaccaccaca tctccagggaggaagaggat 
ATF4 GCAGTGTTGCTGTAACGGACA CGCTGTTCAGGAAGCTCATCT 
JunD TCAAGACCCTCAAAAGCCAGA CGTGGCTGAGGACTTTCTGTT 
hnRNPK GAAGAAACCTTCCCCAACACC CGCAATTCAACCATCTCATCA 
NOS2 CTGAACTTGAGCGAGGAGCAG TTGCCCCATAGGAAAAGACTG 
Ccl2 CAGGTGTCCCAAAGAAGCTGT ATTTGGTTCCGATCCAGGTTT 
Ptgs2 CCTCCTGGAACATGGACTCAC GCTTGTACAGCAATTGGCACA 
Steap4 TGCCATCAGTAAGCAACATGG TACACCAAAGTGTGGGCTGTG 
Cxcl1 TCCAGAGCTTGAAGGTGTTGC TTCTGAACCAAGGGAGCTTCA 
Cxcl2 TGCCAAGGGTTGACTTCAAGA AACTTTTTGACCGCCCTTGAG 
Lrrtm2 ACTGAATGCAGCCTCCAATGT AGGGCAGGCAGCATTTTTAAT 
Lamc2 GGGCAATGCCACTTTTTATGA TCTCTTCATGGCCTCTTCAGC 
Crispld2 TTGGGCTCCTGTGTATGGAAC ACATCTGCATAGCCACCAACC 
Inhba GATCATCACCTTTGCCGAGTC TTCTGCACGCTCCACTACTGA 
GAPDH aggccggtgctgagtatgtc tgcctgcttcaccaccttct 
SOD2 GCCTACGTGAACAATCTCAACG TTGAACTTCAGTGCAGGCTGA 
SOD3 GAGTCCAGCTTCGACCTAGCA CTCCATCCAGATCTCCAGCAC 
ALDH2 GATTGGCGGATCTCATTGAAC TTCAGGACCATGTCCAAATCC 
GPX1 GACTGGTGGTGCTCGGTTTC ACCAGGTCGGACGTACTTGAG 
MGST1 CGCATTCCAGAGGATAACCAA GTTCCACCTTCTCGTCAGTGC 
RDH10 TGTAGACACGGGCATGTTCAG CAGTGAGGATGGCCCTCATAG 
CDO1 TGGGCTTTGTATGCCAAATTC ACCCCAGCACAGAATCATCAG 
SCD1 GCTCAGTCCCTGTTTGTTTGC CTTTGGAGGGTGGACAGACAC 
G6PDX AACCCCAATGGAGAAGGAGAA GAGGACAGCTGCTGCAAAAGT 
DHX9 CCACACAAGTTCCACAGTACATT TTTCCAGGCTCTTCTCCTCTC 
DDX1 AGTGGCAGATGAACCCATATGA CCTCATAGTAGTGCTTCCCTTTC 
DDX3X GAAAATGGAAGATATGGCCGTCG TTCAGCACCACCATAAACCACG 
18S AACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 
Neat1 tcttggggccacattaatcac gaggggcaagagtagggaaga 
PDX1_PT TGAAATCCACCAAAGCTCACG tgaaggcagtagcagccaagt 
 
Table 1. Primer sequences for RT-qPCR 
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2.4  Results 
2.4.1  Establishment of TRAP in Min6 cells 
In order to detect changes in mRNA translation on a genome-wide scale, we 
have employed the Translating Ribosome Affinity Purificaition (TRAP) 
methodology in which expression of a tagged ribosomal subunit (GFP-RPL10A) 
is used to immunoprecipitate ribosomes and their associated mRNA (Doyle et al., 
2008). This approach can be used to detect changes in ribosome occupancy, or 
the density of ribosomes binding to mRNA, which serves as a proxy for the 
efficiency of translation (Zhou et al., 2013b). To use TRAP in Min6 cells, we 
established a stable cell line using retroviral transduction to deliver the GFP-
RPL10A transgene. This allowed for the isolation of intact ribosomes and their 
associated mRNAs by GFP immunoprecipitation (Figure 2.1a-c). To confirm that 
this approach can detect dynamic shifts in ribosome occupancy, TRAP was 
performed in GFP-RPL10A Min6 cells treated with thapsigargin to induce ER 
stress, and ribosome occupancy was determined by normalizing transcript 
abundance in the ribosome pull-down fraction to that in total RNA. This gave a 
near doubling of ribosome occupancy for the stress-responsive factor ATF4 
during thapsigargin treatment (Figure 2.1d), consistent with previous findings 
using polysome profiling (Guan et al., 2014; Hatanaka et al., 2014). 
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Figure 2.1. TRAP in GFP-L10a Min6 cells pulls down ribosome-associated mRNA and 
detects shifts in the ribosome occupancy of ATF4 during ER stress. 
a, Immunoprecipitation of GFP in Min6 cells with stable overexpression of either GFP only or the 
GFP-RPL10A fusion protein, as per TRAP protocol. Compared to GFP only, immunoprecipitation 
of GFP-RPL10A enriches for the ribosomal proteins RPL7 and RPS6. b, Comparison of input 
(Inp) and unbound (UB, supernatant of IP reaction) fractions shows that immunoprecipitation of 
GFP led to depletion of ribosomal proteins RPL10A, RPL7, and RPS6 from the UB fractions for 
GFP-RPL10A Min6 cells, but not for cells only expressing GFP. c, Representative bioanalyzer 
traces on IP RNA showing that TRAP in Min6 cells allows for the isolation of high quality, 
ribosome-associated RNA with overexpression of GFP-RPL10A transgene, but not GFP only. d, 
TRAP in GFP-RPL10a Min6 cells was used to determine ribosome occupancy after 3hr treatment 
with thapsigargin (Tg, 1uM) or vehicle (DMSO), followed by RT-qPCR of IP RNA and Total RNA 
(n=3). P values were calculated by unpaired two-tailed Student’s t-test. * = p < 0.05. 
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2.4.2  TRAP-seq during PDX1 deficiency 
To screen for translationally regulated genes in β cells, we used deficiency of the 
transcription factor PDX1 as a means to disrupt normal β cell homeostasis. PDX1 
is a human diabetes gene (Stoffers et al., 1997b), and reduced PDX1 levels 
cause β cell dysfunction and an impaired stress response (Brissova et al., 2002; 
Sachdeva et al., 2009). Given these connections to human disease and β cell 
stress, we reasoned that PDX1 deficiency was a promising model to uncover 
functionally important translational controls in β cells. Indeed, TRAP-seq on GFP-
RPL10A Min6 cells with siRNA-mediated depletion of PDX1 identified 53 genes 
with an increase in ribosome occupancy after PDX1 depletion while 57 genes 
had a reduction (Figure 2.2a,b). A subset of these genes demonstrated no 
change in total mRNA abundance but a significant change in ribosome 
association (Figure 2.2c), indicating that the dominant regulatory mechanism for 
these genes is post-transcriptional. This list included several genes with known 
importance in β cells such as the transcription factor Nkx2-2, a critical regulator 
of β cell identity and function (Doyle and Sussel, 2007; Gutiérrez et al., 2017). 
We also identified several genes that have been implicated in various stress 
responses in other cell types. Of particular interest was the transcription factor 
JUND, which is important for redox homeostasis in other cell types (Gerald et al., 
2004; Paneni et al., 2013) but whose role in β cells is unknown.  
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Figure 2.2. TRAP in GFP-L10a Min6 detects shifts in ribosome occupancy after PDX1 
depletion. 
a,b, Volcano plot depicting changes in ribosome occupancy with Pdx1 depletion (a) and 
comparison of the change in transcript abundance with Pdx1 depletion in the IP RNA fraction to 
that in the Total RNA fraction (b) as determined by TRAP-seq in GFP-RPL10a Min6 cells 
transfected with siRNA targeting Pdx1 or non-targeting (NT) control (n=3). Significant changes in 
ribosome occupancy shown in red (upregulated) or blue (downregulated). c, Heatmap showing 
genes identified by TRAP-seq as having significant changes in ribosome occupancy but no 
significant change in total RNA levels after Pdx1 depletion. 
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2.4.3  Post-transcriptional regulation by the poly(C)-binding proteins 
To investigate the mechanism underlying the translational regulation of these 
genes, a de novo motif analysis was used to search for a common regulatory 
element within the untranslated regions (UTRs) of genes from our TRAP screen 
(Figure 2.2a). This approach identified 4 motifs as occurring more frequently in 
the UTRs of genes with increased ribosome occupancy than expected by chance 
(Figure 2.3a). However, when compared to the motif frequency (number of motifs 
per sequence length) in UTRs of randomly sampled control genes, two of these 
motifs showed no significant enrichment over controls, indicating they are 
generally enriched in UTRs (Figure 2.3b). In contrast, the motif frequency for the 
cytosine-rich motif 3 was significantly higher in the upregulated genes compared 
to that in both the downregulated genes and control genes, and it was specifically 
enriched in the 3’UTR of the upregulated genes (Figure 2.3b). 31 of the 53 genes 
with increased ribosome occupancy after PDX1 depletion contained at least one 
occurrence of motif 3 in their 3’ UTR. Further, the 3’UTRs of Jund and Nkx2-2 
contain sequence elements matching this cytosine-rich motif.  
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Figure 2.3. Enrichment of a cytosine-rich motif in genes from TRAP-seq identified by de 
novo motif analysis. 
a, Motifs found by de novo motif analysis on UTRs of genes with increased ribosome occupancy 
after PDX1 depletion. b, Assessment of motif frequencies in UTRs of genes with changes in 
ribosome occupancy after PDX1 depletion and sets of randomly sampled control genes. Box, 25–
75th percentile; bar, median; whiskers, range. c, Comparison of Motif 3 to binding motifs for 
hnRNPK, PCBP1, and PCBP2, as depicted. 
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We hypothesized that the cytosine-rich motif 3 serves as the binding site for an 
RBP that post-transcriptionally regulates these target mRNAs. Comparison of 
motif 3 to a database of motifs for RBPs (Ray et al., 2014) found a high similarity 
to the motif recognized by the poly(C)-binding protein family of RBPs, including 
the members PCBP1, PCBP2, and hnRNPK (Figure 2.3c), which are known 
regulators of mRNA translation (Bomsztyk et al., 2004; Makeyev and Liebhaber, 
2002). Indeed, RNA immunoprecipitation (RIP) for PCBP1, PCBP2, or hnRNPK 
demonstrated that the mRNAs encoding JUND and NKX2-2 are significantly 
bound by these RBPs in Min6 cells compared to housekeeping genes (Figure 
2.4a-c). The interaction between hnRNPK and the JUND mRNA was also 
confirmed in eCLIP data for HepG2 and K562 cells and was specifically localized 
in the 3’UTR of this transcript (The ENCODE Project Consortium et al., 2012) 
(Figure 2.4d). 
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Figure 2.4. PCPB1, PCBP2, and hnRNPK bind to the mRNAs encoding NXK2-2 and JUND. 
a-c, Interaction of PCBP1 (a), PCBP2 (b), or hnRNPK (c) with the mRNAs encoding NKX2-2 and 
JUND compared to housekeeping controls, as determined by RNA immunoprecipitation (n=3-4). 
P values were calculated by a two-way ANOVA. * = p < 0.05. d, eCLIP binding peaks for 
hnRNPK show binding in the 3’UTR of JUND in both HepG2 and K562 cells. 
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To broadly examine the connection between hnRNPK and genes from our 
TRAP-seq experiment, RIP for hnRNPK followed by RNA-seq (RIP-seq) was 
performed in Min6 cells treated with glucolipotoxicity (Figure 2.5a). As a control, 
RNA-seq on input RNA was also performed. To determine enrichment for 
hnRNPK binding, the immunoprecipitated RNA was compared to total RNA. An 
IgG control was also performed but not sequenced because no RNA was 
detected in this group. Comparison of RIP-seq and TRAP-seq results showed 
that 64% of genes with increased ribosome occupancy and at least one 
occurrence of motif 3, including JUND and NKX2-2, were enriched for hnRNPK 
binding, constituting a statistically significant overlap (Figure 2.5b, p = 1.0x10-4).  
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Figure 2.5. Detection of mRNAs bound by hnRNPK via RIP-seq. 
a, Comparison of transcript expression level to its enrichment in the hnRNPK IP over total RNA 
as determined by RIP-seq for hnRNPK in Min6 cells treated with glucolipotoxicity. Genes with a 
statistically significant enrichment in hnRNPK binding are shown in red (n=3). b, Comparison of 
the percentage of genes enriched for hnRNPK binding by RIP-seq. Control group is 100 sets of 
100 randomly sampled genes from all expressed genes. Box, 25–75th percentile; bar, median; 
whiskers, range. Increased ribosome occupancy (RO) and decreased RO groups are genes 
determined to have significant changes in RO by TRAP-seq. Motif 3 group is the set of genes that 
had increased RO and contained at least one occurrence of motif 3 in the 3’ UTR.  
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Given the interaction between the PCBPs and the mRNAs encoding JUND and 
NKX2-2, we next investigated whether loss of these RBPs would impact JUND or 
NKX2-2 expression. PCBP1 and PCBP2 have high amino acid sequence 
homology and serve redundant roles for some biological processes. For 
example, co-depletion of PCBP1/2, but not depletion of either individually, leads 
to increased mRNA stability of CDKN1A in K562 cells (Waggoner et al., 2009). 
Therefore, we targeted both PCBP1/2 in Min6 with CRISPR-Cas9, which allowed 
for efficient co-depletion of these factors. Interestingly, loss of PCBP1/2 led to a 
significant reduction in protein levels of NKX2-2 and JUND (Figure 2.6a). In 
contrast, the transcript level of JUND was slightly increased after loss of 
PCBP1/2, indicating that the reduction in protein is not caused by reduced 
transcription, but rather is post-transcriptional (Figure 2.6b). For NKX2-2, there 
was a slight reduction in mRNA levels but a significant increase in primary 
transcript, which was measured using primers spanning an intron-exon junction 
(Figure 2.6b). This is consistent with loss of PCBP1/2 leading to reduced stability 
of the NKX2-2 mRNA and/or reduced mRNA translation. Together, these findings 
implicate PCBP1/2 as post-transcriptional regulators of NKX2-2 and JUND, likely 
through a combination of reduced translation and mRNA stability. In contrast, 
CRISPR-mediated depletion of hnRNPK did not impact protein levels of NKX2-2 
or JUND under baseline conditions (Figure 2.6c). 
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Figure 2.6. Loss of PCBP1/2, but not hnRNPK, reduces NKX2-2 and JUND protein levels 
under baseline conditions. 
a, CRISPR-mediated depletion of PCBP1 and PCBP2 in Min6 cells causes reduction in NKX2-2 
and JUND protein levels 8 days post-transduction, as assessed by Western blot (n=3). b, RT-
qPCR analysis of NKX2-2, NKX2-2 primary transcript (PT), and JUND in Min6 cells with CRISPR-
mediated depletion of PCBP1/2, 8 days post-transduction (n=3). c, Western blot depicting no 
change in NKX2-2 or JUND protein levels after CRISPR-mediated knockout of hnRNPK in Min6 
cells, 8 days post-transduction (n=3). P values were calculated by unpaired two-tailed Student’s t-
test. * = p < 0.05. 
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2.4.4  Impact of the PCBPs on insulin secretion in Min6 cells 
NKX2-2 is a critical regulator of β cell identity, and genetic deletion of NKX2-2 in 
β cells leads to impaired insulin secretion in mice (Gutiérrez et al., 2017). Given 
their role in the post-transcriptional regulation of NKX2-2, we hypothesized that 
loss of PCBP1/2 would also negatively impact insulin secretion. To test this, we 
performed glucose-stimulated insulin secretion assays in Min6 cells after 
CRISPR-mediated depletion of PCBP1/2. As expected, Min6 cells in the 
ROSA26 control group secreted approximately 10 times as much insulin when 
exposed to high glucose levels (25mM) compared to low glucose (2.5mM) 
(Figure 2.7a,b). Interestingly, loss of PCBP1/2 led to a significant reduction in 
insulin secretion at 25mM compared to the ROSA26 group, and it caused a 
reduction in the fold-change from low to high glucose (Figure 2.7a,b). In contrast, 
there was no change in the total insulin content of the cells after loss of PCBP1/2 
(Figure 2.7c), which indicates that there is not a defect in the synthesis of insulin 
but rather in its secretion.  
To assess whether loss of hnRNPK also impacts insulin secretion, we measured 
glucose-stimulated insulin secretion in Min6 cells after CRISPR-mediated 
depletion of hnRNPK. Similar to the PCBP1/2 depletion, loss of hnRNPK led to a 
significant impairment in insulin secretion at high glucose levels compared to the 
ROSA26 group and a reduction in the fold-change from low to high glucose 
concentrations (Figure 2.7d,e). In contrast to PCBP1/2, however, loss of 
hnRNPK led to a significant increase in insulin content, which was independent 
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of changes in insulin mRNA (Figure 2.7f,g). Together these data indicate that 
hnRNPK is required for normal insulin secretion in Min6 cells. This defect cannot 
be explained by reduced insulin levels as there was actually an increase in the 
total insulin content of Min6 cells with depletion of hnRNPK. Instead, these 
findings suggest a secretory defect in these cells. The cause of elevated insulin 
levels is unclear but appears to be independent of insulin mRNA transcription.  
Although loss of hnRNPK did not affect NKX2-2 or JUND levels under baseline 
conditions (Figure 2.6), it did bind to a significant number of genes from our 
TRAP screen containing the polyC motif by RIP-seq. Interestingly, our RIP-seq 
data indicated that hnRNPK binds not only to NKX2-2, but also other 
transcription factors critical for maintenance of β cell identity, including PDX1, 
NKX6-1, and FOXO1. To assess whether loss of hnRNPK may impact β cell 
identity, we depleted hnRNPK in Min6 cells using CRISPR-Cas9 and assessed 
levels of NGN3, a marker of pancreatic endocrine progenitor cells that has been 
used to identify β cell “dedifferentiation” (Talchai et al., 2012). Interestingly, loss 
of hnRNPK led to a significant increase in NGN3 levels in Min6 cells (Figure 
2.7h), suggesting this factor may be important for maintenance of β cell identity.  
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Figure 2.7. Loss of PCBP1/2 or hnRNPK impairs insulin secretion from Min6 cells. 
a-f, Assessment of glucose-stimulated insulin secretion (GSIS) in Min6 cells with CRISPR-
mediated depletion of PCBP1/2 (a-c) or hnRNPK (d-f). Data presented as the amount of insulin 
secreted into media during a 30-minute incubation in low glucose (LG, 2.5mM) or high glucose 
(HG, 25mM) conditions with normalization to the total insulin content of the cells (a,d). GSIS 
results shown as the fold change in insulin secretion from LG to HG conditions (b,e). Total insulin 
content determined for each group with normalization to total protein levels (c,f). For GSIS, each 
group run in quadruplicate. g,h, RT-qPCR analysis of INS1 (n=4) (g) and NGN3 (n=3) (h) in Min6 
cells with CRISPR-mediated depletion of hnRNPK, 8 days post-transduction. P values were 
calculated by unpaired two-tailed Student’s t-test, except in (a,d) in which a 2-way ANOVA was 
used. * = p < 0.05. 
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2.5  Discussion 
To study translational regulation in pancreatic β cells, we have adapted the 
TRAP methodology for use in a Min6 stable cell line expressing the GFP-
RPL10A transgene. One advantage of TRAP over other methodologies, such as 
ribosome profiling, is that expression of the transgene can be controlled in a cell 
type-specific manner. This is particularly attractive for assessing changes in 
ribosome occupancy in vivo as β cells reside alongside other endocrine cell types 
in pancreatic islets. Thus, an exciting and promising direction is to assess 
translational regulation in β cells under in vivo stress conditions, such as a high 
fat diet, using TRAP. This will present some challenges given the limiting material 
of primary islets, however, the continuing improvements in sequencing 
technologies for low input RNA indicate that this approach is likely to be 
successful. 
Another enticing application of this methodology is studying translational 
regulation in human islets by lentiviral delivery of the GFP-L10a transgene 
expressed from a β cell-specific promoter. Since β cells represent a smaller 
fraction of the islet cell population in human compared to mouse islets, the cell 
type specificity of TRAP is particularly important in this context. One large hurdle 
to overcome, however, will be the time required for ribosomal turnover to occur. 
For example, the half-lives of ribosomal proteins were determined to be 
approximately 9 days in rat brain tissue (Retz and Steele, 1980). This suggests 
that it may require prolonged culturing of human islets for a sufficient number of 
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ribosomes to incorporate the GFP-RPL10a protein. The time required for 
adequate incorporation will need to be determined empirically, but limitations on 
culturing human islets for extended periods may cause this approach to be 
problematic.  
As a preliminary TRAP screen, we have used PDX1 deficiency to uncover novel 
translational regulation in β cells. This method, however, could be applied to a 
variety of stresses or stimuli that are relevant for β cell biology. For example, ER 
stress and oxidative stress are thought to contribute to β cell demise in T2D. 
Therefore, a thorough characterization of translational changes that occur in 
response to these stresses may uncover novel mechanisms for adaptation to 
stress. Similarly, high glucose levels have been reported to acutely increase 
translation of insulin mRNA (Itoh and Okamoto, 1980), but the extent to which 
this occurs for other mRNAs under these conditions is unknown. TRAP could 
also be applied to determine the subset of mRNAs translationally regulated by 
particular RNA binding proteins in loss-of-function studies. Taken together with 
genome-wide assessments of RBP binding, such as eCLIP (Van Nostrand et al., 
2016), this could provide a comprehensive picture of the translational targets for 
a particular RBP. 
TRAP can detect shifts in the ribosome occupancy of mRNAs on a genome-wide 
scale, however, it cannot detect changes in the usage of translation initiation 
sites due to the sequencing of full-length mRNA. This is particularly notable 
because translation of an alternative open reading frame of insulin generates an 
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immunogenic peptide that is potentially contributing to type 1 diabetes 
pathogenesis (Kracht et al., 2017). Therefore mapping the usage of alternative 
translation initiation sites on a genome-wide scale, and assessing conditions that 
alter the relative usage of these sites, may advance our understanding of β cell 
autoimmunity. To address this question, TRAP could be adapted to include an 
RNase digestion step prior to immunoprecipitation, which would generate 
ribosome-protected RNA fragments similar to ribosome profiling. This would 
allow for the assessment of ribosome localization along mRNAs while retaining 
the advantage of cell type-specificity.  
A de novo motif analysis on genes from our TRAP screen identified enrichment 
of a poly(C) motif in the 3’ UTR of genes with increased ribosome occupancy, 
which is similar to the preferred binding sequence for the poly(C)-binding protein 
family of RNA binding proteins. Two of the genes with enrichment of this motif 
(NKX2-2 and JUND) are also bound by the PCBPs by RIP and require PCBP1/2 
for normal expression under baseline conditions. These data suggest that these 
RBPs directly regulate the expression of NKX2-2 and JUND. However, we 
cannot rule out the possibility that loss of PCBP1/2 indirectly affects the 
expression of these genes. One approach to expand on the level of regulation is 
to use a reporter gene flanked by the 5’ and 3’UTR of the gene of interest. 
Deletion constructs can then be generated to assess the importance of the 
poly(C) regions for maintaining normal expression levels or for the control of 
stress-dependent changes in expression. Although this approach is commonly 
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used for this purpose, we have been unsuccessful in our attempts to model the 
regulation of NKX2-2 or JUND using reporter assays. There are many reasons 
that an artificial reporter gene may not fully recapitulate the complex regulation of 
endogenous genes. For example, RNA secondary structure may be altered due 
to presence of remaining plasmid sequence, or the assembly of RNP complexes 
may require factors recruited by the local chromatin environment. Nevertheless, 
we cannot currently rule out the possibility that the PCBPs regulate NKX2-2 or 
JUND independent of binding to 3’UTR poly(C) motifs. In the future, it would be 
interesting to generate deletions of the poly(C) motifs by genome editing to 
assess their impact on gene expression and stress adaptation.  
Loss of PCBP1/2 or hnRNPK leads to impaired glucose-stimulated insulin 
secretion in Min6 cells. As an insulinoma cell line, Min6 cells are an imperfect 
model of primary β cells. However, our methodology provides a robust increase 
in insulin secretion from Min6 cells during high glucose conditions compared to 
low glucose, suggesting these cells are a useful model for preliminary 
experiments. To follow-up on these results, our lab is actively characterizing the 
impacts of β cell-specific ablation of PCBP1 and PCBP2 in vivo on glucose 
homeostasis and insulin secretion. 
The exact mechanisms by which loss of PCBP1/2 or hnRNPK reduces insulin 
secretion are currently unclear. In both cases, total cellular insulin levels cannot 
explain this phenotype, but rather there is likely a secretory impairment in these 
cells. One useful approach to further localize this defect along the pathway of 
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glucose-stimulated insulin secretion is calcium imaging. For example, if loss of 
these RBPs was associated with normal glucose-stimulated calcium influx, it 
would suggest there is not a problem with glucose sensing but rather in a more 
distal step such as insulin granule exocytosis. An in-depth investigation of the 
mRNA targets regulated by the PCBPs in β cells will also shed light on the 
precise cause of the impaired insulin secretion. This objective is complicated by 
the fact that the PCBPs can regulate gene expression at many levels including 
transcription, splicing, mRNA stability, and translation. Nevertheless, a 
systematic examination of gene expression changes downstream of PCBP 
depletion holds promise to elucidate novel regulatory networks governing β cell 
functionality. 
Loss of β cell identity has received growing attention as a cause of impaired 
insulin secretion in T2D. Therefore, it will be important to identify the full inventory 
of factors shaping β cell identity and to understand the dynamics and adaptability 
of these gene regulatory networks during environmental perturbations. Our 
finding that loss of hnRNPK in Min6 cells leads to an upregulation of NGN3, a 
marker of endocrine progenitor cells, suggests that hnRNPK may be a novel 
regulator of β cell identity. On the other hand, hnRNPK depletion leads to 
increased insulin levels in Min6 cells, which seems to contradict the adoption of 
an endocrine progenitor fate. One explanation for these findings is that loss of 
hnRNPK leads to the formation of distinct subpopulations of cells, including a 
66	  
	  
subset of NGN3+ cells. An interesting approach to assess this possibility is 
performing single cell RNA-seq on β cells after depletion of hnRNPK.  
The role of hnRNPK in regulating β cell identity is particularly interesting because 
it can integrate various signaling pathways with multiple levels of gene 
expression, allowing for the swift reshaping of regulatory networks. hnRNPK 
binds to the mRNAs of several genes with critical roles in β cell identity, including 
NKX2-2, PDX1, NKX6-1, and FOXO1. However, we have been unable to identify 
changes in the expression level of NKX2-2 or PDX1 with loss of hnRNPK. One 
possible explanation for these findings is that hnRNPK regulates these genes 
under stress conditions or as cells recover from stress, but not under baseline 
conditions. PCBP1/2 may also be important for maintenance of β cell identity as 
loss of these factors leads to reduced NKX2-2 levels. An active area of 
investigation for our lab is to better understand whether PCBP1/2 depletion 
causes loss of β cell identity and reprogramming to a new cell type. 	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CHAPTER 3: JUND PROMOTES β CELL APOPTOSIS AND OXIDATIVE 
STRESS DURING METABOLIC STRESS 
3.1  Summary 
During the development of T2D, prolonged oxidative stress conditions contribute 
to β cell dysfunction and apoptosis; however, the factors shaping the oxidative 
stress response in β cells is poorly understood. By focusing on translational 
regulation, we have identified the transcription factor JUND as a potential stress-
responsive factor in β cells. Indeed, exposure of mouse islets or Min6 cells to 
metabolic stress caused by high glucose and free fatty acid levels leads to the 
translational induction of JUND. This post-transcriptional regulation of JUND also 
occurs during in vivo stress conditions and is conserved in human islets. 
Surprisingly, depletion of JUND in β cells reduces oxidative stress and apoptosis 
caused by metabolic stress. Consistent with this, JUND regulates the 
transcription of pro-oxidant and pro-inflammatory genes in β cells. Furthermore, 
there is a significant overlap between JUND target genes and genes increased in 
islets from diabetic db/db mice. Thus, we have uncovered the novel translational 
regulation of JUND during metabolic stress and implicate this transcription factor 
in activating a maladaptive response in β cells during pathophysiologically 
relevant conditions.  
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3.2  Introduction 
In T2D, β cell dysfunction occurs due to prolonged stress conditions that impact 
the function and viability of these cells. Of particular importance is chronic 
oxidative stress, or the accumulation of reactive oxygen/nitrogen species 
(ROS/RNS) in the cell. Chronic oxidative stress has been suggested to impact 
various aspects of β cell function including reduced expression of key β cell 
genes such as those encoding insulin, PDX1, and MAFA (Jonas et al., 1999; 
Robertson et al., 2007). In fact, β cells are though to be particularly vulnerable to 
oxidative stress due to low expression of antioxidant genes (Lenzen et al., 1996). 
Furthermore in animal models of diabetes, antioxidant treatment can reverse the 
onset of hyperglycemia by improving β cell function (Han et al., 2015), however, 
the use of antioxidants for treatment of humans with T2D has as of yet not 
proven beneficial (Rochette et al., 2014).  
The cause of oxidative stress in β cells during T2D is complex and may be 
manifold. Part of this complexity arises due to the generation of ROS in various 
cellular compartments. For example, ROS are a normal byproduct of oxidative 
phosphorylation in mitochondria, and increased flux through the electron 
transport chain can cause increased mitochondrial oxidative stress (Sakai et al., 
2003). On the other hand, high levels of free fatty acids cause lipid oxidation to 
occur predominantly in peroxisomes, leading to hydrogen peroxide generation in 
this organelle (Gehrmann et al., 2010). Additionally, many cytoplasmic enzymes, 
such as NADPH oxidases, generate ROS and may be induced in β cells under 
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stress conditions, such as cytokine treatment (Weaver et al., 2014). It is unclear 
to what extent these different sources of ROS contribute to β cell dysfunction in 
T2D. This is further complicated by the fact that different models of β cell stress 
(ie: glucotoxicity vs. lipotoxicity) implicate different ROS sources as the critical 
mediators of dysfunction (Elsner et al., 2010; Sakai et al., 2003). 
Despite extensive evidence linking oxidative stress to β cell demise in T2D, the 
factors shaping the oxidative stress response in β cells, and how these factors 
are regulated during disease progression, are unclear. For this reason, we were 
particularly interested in further exploring our finding that the transcription factor 
JUND may be translationally regulated in β cells (Figure 2.2), because this factor 
has been linked to redox homeostasis in other cell types (Gerald et al., 2004; 
Paneni et al., 2013). 
JUND is a member of the Jun family of transcription factors, which also includes 
C-JUN and JUNB. These factors form either homo- or hetero-dimers among 
themselves or with factors from other transcription factor families, including Fos, 
Atf, and Maf. Importantly, the composition of these dimers will dictate the DNA 
binding preference and transcriptional effect of JUND (Mechta-Grigoriou et al., 
2001). Consequently, the transcriptional and phenotypic effects of JUND may 
vary across cell types based on the relative abundance of its binding partners.  
The effect of JUND on oxidative stress has mostly been studied in the context of 
a global JUND knockout mouse model. Fibroblasts and endothelial cells isolated 
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from these mice display elevated ROS levels compared to those from wild type 
mice, which was linked to reduced expression of antioxidant genes (Gerald et al., 
2004; Paneni et al., 2013). JUND knockout mice have a shortened lifespan and 
hyperinsulinemic hypoglycemia, and pancreatic islets from these mice are 
hypervascularized (Laurent et al., 2008). However, whether loss of JUND also 
causes cell-autonomous changes in β cells has not been explored. 
Although the role of JUND in β cells has not been studied, it is worth noting that 
one factor known to interact with JUND and regulate its function is MENIN, a 
transcriptional cofactor with repressive function. Mutations in the gene encoding 
this cofactor, Men1, cause multiple endocrine neoplasia, type 1 (MEN1). This 
disorder is characterized by tumors of the pancreatic islets, parathyriods, anterior 
pituitary, and duodenum (Feng et al., 2017). MENIN represses the transcriptional 
activity of JUND (Agarwal et al., 1999), raising the intriguing possibility that JUND 
may be important for regulating β cell proliferation. However, whether this 
interaction between JUND and MENIN is important for the role of either factor in 
β cells is unknown.  
One approach to address the role of JUND in β cells would be to use a mouse 
model in which the gene encoding JUND is flanked by loxP sites to allow for its 
conditional ablation using a β cell-specific Cre driver. Unfortunately, a JUND 
conditional knockout mouse is currently unavailable. To circumvent this problem, 
we have used lentiviral delivery of an shRNA targeting JUND from the rat insulin 
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promoter to achieve β cell-specific depletion of JUND in primary mouse islets, 
leading to our novel findings that depletion of JUND in β cells reduces apoptosis 
and oxidative stress during glucolipotoxicity.  
	  
72	  
	  
3.3  Materials and Methods 
Animals 
Animal studies were approved by the University of Pennsylvania Institutional 
Animal Care and Use Committee. Wild type CD1 males were purchased from 
Jackson Laboratory. Male db/db mice (C57BLKS/J Leprdb/db) or db/+ mice 
(C57BLKS/J Leprdb/+) were purchased from Jackson Laboratory. Blood glucose 
levels were determined by handheld glucometers (One Touch). Serum NEFA 
levels were determined by fluorometric assay (Abcam). Mice were housed in a 
12hr light/dark cycle and had ad libitum access to food. 
Lentivirus production 
293T cells were transfected for 8 hrs in OptiMEM using Lipofectamine 2000 
(Invitrogen), after which the media was changed to standard high glucose 
DMEM. psPAX2 and pMD2.G were used for packaging and envelope vectors. 
These plasmids were a gift from Didier Trono (Addgene plasmid #12260 and # 
12259). Media containing virus was collected 2 and 3 days post-transfection. 
Ultracentrifugation of collected media (19,000rpm for 1.5hrs at 4°C) was used to 
concentrate virus. Lentivirus was titered by RT-PCR (Sastry et al., 2002). 
Islet isolation and culture 
Mouse islets were isolated from 6-12 week old CD1 male mice unless otherwise 
noted. Briefly, ductal inflation of the pancreas was performed followed by 
collagenase digestion (Roche 11213873001). Islets were enriched by density 
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gradient centrifugation with Ficoll-Paque (GE 45-001-751). After handpicking 3-4 
times, islets were collected for RNA/protein isolation or cultured overnight for 
recovery from isolation and stress treatments were started the next day.  
Human islets were obtained through the NIH-supported Human Pancreas 
Analysis Program via the University of Pennsylvania Islet Core facility. The islets 
were harvested from non-diabetic deceased donors without any identifying 
information at NIH-approved centers with informed consent and IRB approval at 
the islet isolation centers. Human islet donor characteristics are provided below 
in Table 2. 
The culture media used for mouse and human islets was RPMI 1640 (11mM 
glucose) supplemented with 10% FBS, 2mM glutamine, 1mM sodium pyruvate, 
10mM HEPES, 1% antibiotic antimycotic (Thermo 15240096), and pH was 
adjusted to 7.3-7.4. 
Islet transductions 
Lentiviral infection of mouse islets was performed as described (Jimenez-Moreno 
et al., 2015). 100-200 islets were cultured overnight in serum-free islet media 
containing lentivirus at an MOI of 20. 
Palmitate preparation and glucolipotoxicity conditions 
Palmitate (Sigma P9767) was dissolved in 50% ethanol at 65°C and diluted in 
10% BSA to a concentration of 7mM. The mixture was incubated at 37°C for 1 
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hour to allow for conjugation before diluting in culturing media to a final 
concentration of 0.5mM. Control media was made by performing the same 
procedure with 50% ethanol and no palmitate.  
For islets, control media (described above) contained 11mM glucose with no 
added palmitate. Media for glucolipotoxic conditions contained 25mM glucose 
with 500uM palmitate. 
For Min6, control media (DMEM) contained 5.6mM glucose with no added 
palmitate while glucolipotoxic conditions had 25mM glucose and 500uM 
palmitate. 
RNA isolation and RT-qPCR 
For islets, handpicked islets were washed 2X with cold PBS and RNA was 
extracted using RNeasy Mini Kit (Qiagen). RNA was reverse transcribed using 
oligo(dT) and Superscript III (Invitrogen). Quantitative PCR (BioRad CFX384) 
was used to measure transcript abundance and normalized to HPRT. See Table 
1 for a list of primer sequences used for these analyses. 
Western blot 
Proteins were separated by SDS-PAGE and immunoblotted with the following 
antibodies: rabbit anti-JUND (Santa Cruz, sc-74), mouse anti-ATF4 (Santa Cruz, 
sc-390063), rabbit anti-cleaved caspase-3 (Cell Signaling, 9664S), mouse anti-
Tubulin (Sigma, T9026), and mouse anti-Ran (B.D. 610340). 
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Cycloheximide chase assay 
Min6 cells were cultured in control or glucolipotoxic conditions for 30hrs prior to 
treatment with cycloheximide at a concentration of 200ug/mL. Cells here 
harvested at 0hr, 3hr, 6hr, and 9hr time points post-cycloheximide treatment and 
analyzed by western blot. 
shRNA design and cloning 
The lentiviral backbone was generated by cloning the rat insulin II promoter (-405 
to +7 relative to the TSS), GFP, and the UltramiR mir-30 scaffold (Knott et al., 
2014) into pLenti CMV puro (Campeau et al., 2009) by PCR and Gibson 
Assembly (replaced CMV promoter with rat insulin promoter). shRNA sequences 
were designed using the shERWOOD algorithm (Knott et al., 2014) (shJunD: 
AGCAGCTCAAACAGAAAGTCC, shNT: GCGCGATAGCGCTAATAATTT).  
CRISPR design and cloning 
CRISPR gRNAs were designed using http://crispr.mit.edu/ to minimize off-target 
binding (ROSA26: AAGATGGGCGGGAGTCTTCT, JUND: 
CAGCTTGCGCTTGCGGCATT). gRNAs were cloned into lentiCRISPR v2, as 
described (Sanjana et al., 2014). 
Immunofluorescence staining of isolated islets  
Transduced islets were collected, dispersed to single cell suspension, washed in 
PBS, and fixed for 10 minutes at room temperature in 4% PFA. Fixed cells were 
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attached to slides using cytospin. Following permeabilization (0.1% Triton x-100 
for 10 min at room temperature), immunofluorescence staining was performed 
using the following antibodies: guinea pig anti-insulin (Dako, A0564) and goat 
anti-GFP (Abcam, 6673). Images were taken on a Keyence BZ-X700 microscope 
and images were analyzed using the BZ-X Advanced Analysis Software. 
Oxidative stress measurement 
For mouse islets, following stress treatment, 50-100 intact islets were transferred 
to a polysterene round bottom tube and CellROX Deep Red Reagent (Invitrogen) 
was added at 1:500 dilution to culture media followed by incubation at 37°C for 
45 min. Islets were washed 2X with PBS, dispersed to single cell suspension, 
attached to slides using cytospin, and imaged using fluorescence microscopy 
(Keyence BZ-X700 microscope). GFP signal was used to identify transduced 
cells and the CellROX signal from each cell was quantified and normalized by 
cell area using BZ-X Advanced Analysis Software. Signal from at least 60 GFP 
positive cells was assessed for each condition per experiment. 
For Min6 cells, following stress treatment, CellROX Deep Red Reagent 
(Invitrogen) was added at 1:500 dilution directly to culture media followed by 
incubation at 37°C for 30 min. Cells were washed 2X with PBS and imaged using 
fluorescence microscopy (Keyence BZ-X700 microscope). Bright field images 
were used to determine cell areas and CellROX signal was quantified from at 
least 6 imaging fields for each group using BZ-X Advanced Analysis Software. 
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Caspase-3 and-7 activation assay 
Following stress treatment, 50-100 intact islets were transferred to a polysterene 
round bottom tube and fluorescent inhibitor of caspases (FLICA) reagent (Image-
iT LIVE Red Caspase-3 and -7 Detect kit, Invitrogen) was added at 1:150 dilution 
followed by incubation at 37°C for 1 hour. Islets were washed 2X with wash 
buffer (provided by manufacturer), dispersed to single cell suspension, attached 
to slides using cytospin, and imaged using fluorescence microscopy (Keyence 
BZ-X700 microscope). Double positive cells were determined using BZ-X 
Advanced Analysis Software, and at least 200 GFP positive cells were counted 
for each condition per experiment. 
RNA-seq and analysis 
RNA was isolated using the RNeasy Mini Kit (Qiagen). Libraries were prepared 
using NEB Next Ultra RNA Library Prep Kit according to manufacturer’s 
instructions with polyA enrichment followed by paired-end sequencing of 150bp 
using HiSeq (Illumina). Reads were mapped to mm10 using TopHat2 (Kim et al., 
2013) and read counts per gene were determined using featureCounts (Liao et 
al., 2014). Differential expression analysis was performed using edgeR 
(Robinson et al., 2010) with significant genes called using fold-change cutoffs of 
greater than 1.5 or less than -1.5 and FDR less than 0.05. Gene ontology 
analysis was performed using DAVID (Huang et al., 2009). The overlap between 
RNA-seq data sets was determined using hypergeometric tests.  
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Statistics 
Data are presented as mean ± standard error of the mean unless otherwise 
noted in figure legends. Statistical analyses were performed using GraphPad 
PRISM 7 software. Statistical tests used are noted in figure legends and include 
unpaired two-tailed Student’s t-test, one-way analysis of variance (ANOVA), two-
way ANOVA, and hypergeometric test. 
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 Gender Age Race BMI Medical History HbA1c 
Cold 
ischemia 
time (hr) 
Cause of 
death 
Donor 1 F 39 Caucasian 34.8 Non-diabetic 4.7 8:33 
Anoxia, drug 
intoxication 
Donor 2 M 24 Caucasian 20.8 Non-diabetic 4.9 16:27 
Anoxia, drug 
intoxication 
Donor 3 F 31 Caucasian 32.7 Non-diabetic 4.4 9:59 
Anoxia, 
cardiovascular 
Donor 4 M 23 unknown - Non-diabetic 5.3 - 
Anoxia, drug 
intoxication 
 
Table 2. Human islet donor characteristics 
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3.4  Results 
3.4.1  Translational upregulation of JUND in β cells during metabolic stress 
Our TRAP-seq results indicated that a subset of genes had increased ribosome 
occupancy in Min6 cells with PDX1 deficiency despite no change in mRNA 
abundance (Figure 2.2c). Of particular interest was the transcription factor JUND, 
which is important for redox homeostasis in various cell types (Gerald et al., 
2004; Paneni et al., 2013). Given the particular vulnerability of β cells to oxidative 
stress (Lenzen et al., 1996; Robertson et al., 2003), we hypothesized that JUND 
plays an important, but as of yet unappreciated, role during the β cell stress 
response. 
We first investigated whether JUND upregulation extends to other stress 
conditions with relevance for T2D pathophysiology. To this end, we exposed 
mouse islets to a panel of stressors, including hydrogen peroxide (oxidative 
stress), high levels of glucose and the free fatty acid palmitate, termed 
glucolipotoxicity (metabolic stress), and thapsigargin (ER stress). While ATF4 
was upregulated in all of these stress models, JUND was only induced by 
metabolic stress (Figure 3.1a). Despite the increase in JUND protein levels 
during glucolipotoxicity, there was no change in the abundance of JUND mRNA 
(Figure 3.1b). This discordance could be caused by either an increase in the 
translation of JUND mRNA or an increase in the stability of JUND protein. A 
TRAP assay performed in GFP-RPL10A Min6 cells during metabolic stress 
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showed a significant shift towards greater ribosome occupancy of the JUND 
mRNA (Figure 3.1c), consistent with increased translation of JUND mRNA during 
glucolipotoxicity. We next performed a cycloheximide chase assay in Min6 cells 
and found no increase in JUND protein stability during glucolipotoxicity (Figure 
3.1d,e). Furthermore, there was no difference in TUBULIN levels throughout the 
time course between the two treatment groups, providing an additional control for 
the experiment (Figure 3.1f). We also confirmed that there was a significant 
induction of JUND protein levels at the 0hr time point (Figure 3.1g). Together, 
these data indicate that JUND is translationally upregulated in β cells during 
metabolic stress. 
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Figure 3.1. JUND is translationally upregulated in β cells during metabolic stress. 
a, Western blot depicting ATF4 and JUND levels in mouse islets treated with hydrogen peroxide 
(H2O2, 200uM) for 1 hr, glucolipotoxicity (GLT, 25mM glucose, 500uM palmitate) for 2 days, or 
thapsigargin (Tg, 1uM) for 3 hrs (n=3). b, Increased protein levels of JUND as determined by 
Western blot, but not transcript levels by RT-qPCR, in mouse islets treated with glucolipotoxicity 
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for 2 days (n=5). c, Increased ribosome occupancy of JUND in GFP-RPL10a Min6 cells after 30 
hours of glucolipotoxic conditions, as determined by TRAP followed by RT-qPCR (n=3). d, 
Representative western blot depicting reduction in JUND protein levels at indicated times after 
addition of cycloheximide (CHX) to Min6 cells. CHX added after culturing for 30hrs in control or 
glucolipotoxic (GLT) culturing conditions (n=3). e,f, Quantification of western blot signal for JUND 
(e) or TUBULIN (f) normalized to RAN. Each group normalized to value at 0hr time point to depict 
reduction in protein over time. g, Quantification of JUND western blot at 0hr time points with 
normalization to the control group to depict increased JUND levels prior to CHX addition. P 
values were calculated by unpaired two-tailed Student’s t-test, except in (e,f) in which a two-way 
ANOVA was used. For Western blot images of JUND, arrows denote two bands for JUND and * 
denotes a non-specific band. Otherwise, * = p < 0.05. Cont denotes control culturing conditions 
and GLT denotes glucolipotoxic culturing conditions. 
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To determine if this induction of JUND also occurs in β cells under metabolic 
stress in vivo, we used 12-week-old db/db mice, which are obese with elevated 
serum glucose and free fatty acid levels (Figure 3.2a-c). Indeed, compared to 
non-diabetic db/+ mice, islets from db/db mice had a significant increase in JUND 
protein, but not mRNA (Figure 3.2d). Thus, we have uncovered the post-
transcriptional upregulation of JUND as a novel component of the β cell response 
to metabolic stress. 
To extend these findings to a human model, we assessed the induction of JUND 
during metabolic stress by culturing human islets with high levels of glucose and 
palmitate. Consistent with our findings in mouse islets, this excess of metabolic 
fuel caused an increase in JUND protein levels in human islets (Figure 3.2e), 
indicating that the induction of JUND during metabolic stress is conserved in 
humans.  
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Figure 3.2. Post-transcriptional induction of JUND in islets from db/db mice and in human 
islets during metabolic stress. 
a-c, Compared to age- and gender-matched db/+ mice, db/db male mice at 12-weeks of age had 
increased body weight (a), blood glucose levels (b), and serum non-esterified fatty acid levels (c). 
n = 3-4 per group. d, Western blot showing increased JUND levels in islets isolated from db/db 
mice compared to db/+ at 12 wks of age. No change in JUND transcript as determined by RT-
qPCR (n=3). e, Representative Western blot showing increased JUND levels in human islets 
treated with glucolipotoxic (GLT) conditions for 2 days. Quantification of results from four human 
donors are shown. * = p < 0.05. P values were calculated by unpaired two-tailed Student’s t-test. 
For Western blot images of JUND, arrows denote two bands for JUND and * denotes a non-
specific band. Otherwise, * = p < 0.05. 
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3.4.2  β cell-specific depletion of JUND in primary islets 
To study the function of JUND during metabolic stress, we developed a system 
for β cell-specific depletion of JUND in isolated islets. To this end, we adopted a 
protocol to allow for efficient transduction of primary islets with lentiviral 
constructs (Jimenez-Moreno et al., 2015). Initial attempts to deplete genes using 
lentiviral delivery of CRISPR-Cas9 were unsuccessful in primary mouse islets, 
thus we decided to use an shRNA system. A lentiviral vector was constructed to 
co-express GFP and an shRNA from the rat insulin promoter, and its functionality 
was confirmed in Min6 cells (Figure 3.3a,b). Lentiviral transduction of intact 
mouse islets was used to deliver shRNA constructs, followed by a recovery 
period in culture media. To assess transduction efficiency, islets were dispersed 
and assessed for GFP positivity by immunofluorescence staining. Nearly half of 
all islet cells were GFP positive, and all GFP positive cells stained positive for 
insulin, indicating efficient and β cell-specific transgene delivery (Figure 3.3c). 
Further, the shRNA targeting JUND provided a 50% reduction in its transcript 
level (Figure 3.3c), similar to the rate of transduction and suggesting a robust 
depletion of JUND in those cells expressing the transgene. 
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Figure 3.3. β cell-specific depletion of JUND in mouse islets via lentiviral delivery of 
shRNA. 
a, Schematic depicting shRNA system for β cell-specific depletion of JunD. b, Depletion of JunD 
transcript in Min6 cells transduced with shRNA targeting JunD or non-targeting control (n = 5). c, 
Immunofluorescence images showing β cell-specific expression of GFP in half of mouse islet 
cells after lentiviral transduction. Arrows denote β cells staining positive for GFP. Delivery of 
shRNA targeting JUND provides a significant reduction in JUND transcript compared to a non-
targeting (NT) control (n=3-4). * = p < 0.05. Significance determined by unpaired two-tailed 
Student’s t-test. 
88	  
	  
3.4.3  Reduced oxidative stress in β cells with JUND depletion during 
metabolic stress 
Chronically elevated glucose and free fatty acid levels cause β cell dysfunction 
and apoptosis at least partly due to increased oxidative stress (Piro et al., 2002; 
Poitout and Robertson, 2008), but whether JUND contributes to β cell redox 
homeostasis during metabolic stress is unknown. As expected, β cells exposed 
to glucolipotoxicic conditions showed elevated oxidative stress as seen by 
increased fluorescence from an oxidation-sensitive dye (Figure 3.4a,b). If JUND 
were playing an antioxidant role in β cells, we predicted that there would be an 
exacerbation of oxidative stress caused by glucolipotoxicity. Surprisingly, 
however, depletion of JUND in β cells blocked the increase in oxidative stress 
caused by high levels of glucose and palmitate (Figure 3.4a,b). This is in contrast 
to findings in other cell types where loss of JUND leads to elevated reactive 
oxygen species (ROS) levels (Gerald et al., 2004; Paneni et al., 2013), 
highlighting the cell-type specificity of this factor. This prevention of redox 
imbalance during metabolic stress was also observed in Min6 cells with CRISPR-
mediated depletion of JUND compared to a control group with a gRNA targeting 
the ROSA26 locus (Figure 3.4c,d). 
89	  
	  
 
Figure 3.4. β cell-specific depletion of JUND in mouse islets reduces oxidative stress 
during glucolipotoxicity. 
a,b, Assessment of oxidative stress in β cells transduced with shRNA vectors targeting JUND or 
NT control by fluorescence imaging of CellROX Deep Red reagent. Whole mouse islets cultured 
for 2 days in control or glucolipotoxic conditions prior to oxidative stress assessment. 
Representative fluorescence image for GFP and CellROX in islet cells after cytospin and 
frequency distribution of CellROX signal (a) and quantification of CellROX signal in GFP positive 
cells (b). The frequency distribution of CellROX intensity is a representative finding and the 
averages are for 3 independent experiments. c, Western blot showing depletion of JUND in Min6 
cells using lentiviral delivery of CRISPR-Cas9. A gRNA targeting the ROSA26 locus is used as a 
negative control. d, Quantification of CellROX signal in Min6 cells with CRISPR-mediated 
depletion of JUND after culturing in glucolipotoxic conditions for 30hrs (n=4). P values were 
calculated by two-way ANOVA. For Western blot images of JUND, arrows denote two bands for 
JUND and * denotes a non-specific band. Otherwise, * = p < 0.05. Cont denotes control culturing 
conditions and GLT denotes glucolipotoxic culturing conditions.  
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3.4.4  Reduced apoptosis in β cells with JUND depletion during metabolic 
stress 
β cells are thought to be particularly sensitive to oxidative stress due to low 
expression of antioxidant genes (Lenzen et al., 1996). Thus, we investigated 
whether the impact of JUND on redox homeostasis would also affect β cell 
apoptosis during metabolic stress. Using a fluorescence readout of caspase-3/7 
activation, there was a 3-fold increase in the number of apoptotic β cells after 
culturing islets with high levels of glucose and palmitate for 3 days (Figure 3.5a). 
Consistent with its impact on redox imbalance, depletion of JUND significantly 
reduced this induction of apoptosis during metabolic stress (Figure 3.5a). This 
improvement in cell survival was confirmed in Min6 cells as CRISPR-mediated 
depletion of JUND completely abrogated the increase in cleaved caspase-3 
levels caused by metabolic stress (Figure 3.5b). 
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Figure 3.5. β cell-specific depletion of JUND in mouse islets reduces apoptosis during 
glucolipotoxicity. 
a, Assessment of apoptosis in transduced β cells by fluorescence imaging of FLICA reagent, 
which marks apoptotic cells as red, after 3 days of culturing mouse islets in control or 
glucolipotoxic conditions. The percentage of GFP positive cells that were apoptotic were 
averaged for 3 independent experiments. b, Western blot of cleaved caspase-3 used to assess 
apoptosis in Min6 cells with CRISPR-mediated depletion of JUND and cultured in glucolipotoxic 
conditions for 30hrs (n=3). P values were calculated by two-way ANOVA. For Western blot 
images of JUND, arrows denote two bands for JUND and * denotes a non-specific band. 
Otherwise, * = p < 0.05. Cont denotes control culturing conditions and GLT denotes glucolipotoxic 
culturing conditions.  
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3.4.5  JUND regulates pro-oxidant and pro-inflammatory genes in β cells  
In accordance with the distinct pro-oxidant role of JUND in β cells, none of the 
antioxidant genes reported to be targets of JUND in other cell types was 
dysregulated in β cells (Figure 3.6a). This indicates that both the transcriptional 
and phenotypic effects of JUND are cell-type specific. To investigate how JUND 
impacts redox homeostasis and cell survival in β cells, we assessed the 
transcriptome of Min6 cells cultured with high levels of glucose and palmitate 
after CRISPR-mediated depletion of JUND, leading to the identification of 27 
downregulated genes and 10 upregulated genes (Figure 3.6b). Gene ontology 
analysis on the downregulated genes demonstrated a significant enrichment in 
processes including stress response, ROS metabolism, and inflammation (Figure 
3.6c). β cell-specific depletion of JUND in mouse islets confirmed most of these 
genes to indeed be targets of JUND in primary β cells (Figure 3.6d). Interestingly, 
several of these genes, including Nos2, Ptgs2, and Steap4, encode proteins with 
enzymatic activity leading to ROS generation (Jin et al., 2015; Maciag, 2004; 
Tabatabaie et al., 2003; Xia and Zweier, 1997; Zhou et al., 2013a). Thus, JUND 
induction during metabolic stress likely contributes to β cell demise by activating 
several deleterious genes, including pro-oxidants. Indeed, these JUND targets 
were increased in mouse islets exposed to high levels of glucose and palmitate 
(Figure 3.6e). Strikingly, nearly half of the genes downregulated with depletion of 
JUND were previously identified via RNA-seq to be upregulated in islets from 
diabetic db/db mice (Neelankal John et al., 2018) (Figure 3.6f), constituting a 
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statistically significant overlap (Figure 3.6g, p = 6.0x10-5). The JUND target 
genes also significantly overlapped with genes upregulated during PDX1 
deficiency (Figure 2.2) or after treatment of human islets with palmitate (Cnop et 
al., 2014) (Figure 3.6g). Together, these findings indicate that JUND regulates a 
set of genes that are commonly increased in models of β cell dysfunction. 
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Figure 3.6. JUND regulates pro-oxidant and pro-inflammatory genes associated with β cell 
stress and dysfunction. 
a, RT-qPCR analysis of mouse islets with shRNA-mediated depletion of JUND for panel of genes 
reported to be downregulated with loss of JUND in denoted publications (n=3). b, Volcano plot 
depicting changes in transcript levels after JUND depletion in Min6 cells cultured in glucolipotoxic 
conditions for 30hrs, as determined by RNA-seq (n=3). Significant changes shown in red 
(upregulated) or blue (downregulated). c, Gene ontology analysis for downregulated genes. d, 
RT-qPCR panel of select JUND target genes in mouse islets with shRNA-mediated depletion of 
JUND (n=3). e, Increased transcript levels of JUND target genes in mouse islets cultured for 2 
days in glucolipotoxic (GLT) conditions (n=3). f, Heatmap of the genes downregulated after JUND 
depletion with detectable expression in islets from db/db mice. The change in expression after 
JUND depletion (JUND KO) is compared to the change in expression in islets from db/db vs db/+ 
mice. Genes with an asterisk had a statistically significant change in both data sets. g, The 
significance of the overlap between gene sets is plotted. Genes downregulated after JUND 
depletion are compared to genes upregulated in islets from db/db mice, with PDX1 depletion in 
Min6 cells, or in human islets treated with palmitate (PA). P values were calculated by unpaired 
two-tailed Student’s t-test (a,d,e) or hypergeometric tests (g). * = p < 0.05, unless otherwise 
noted. 
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3.5  Discussion 
Oxidative stress has long been recognized as a major contributor to β cell 
demise in T2D, thus new insights into the molecular mechanisms controlling 
redox homeostasis in β cells are central to our understanding of diabetes 
pathophysiology. Here, we have used a translation-centric approach to uncover 
JUND as a stress-responsive gene and a novel regulator of β cell redox 
homeostasis. JUND was upregulated in isolated mouse and human islets 
exposed to metabolic stress, as well as islets from diabetic db/db mice, indicating 
that this response is conserved across species and relevant for in vivo stress 
conditions. In β cells, JUND depletion dampens oxidative stress caused by the 
presence of excess metabolic fuel, which is in contrast to reports in other cell 
types where loss of JUND enhances oxidative stress due to downregulation of 
antioxidant genes (Gerald et al., 2004; Paneni et al., 2013). Although this 
discrepancy was unexpected, the cell-type specific function of JUND is 
consistent with its ability to dimerize with a variety of binding partners, which 
likely shapes its tissue specific effects (Hai and Curran, 1991). Further, the 
amelioration of ROS accumulation with JUND depletion agrees with our finding 
that JUND positively regulates several genes with the capacity to increase ROS 
production in β cells, including Ptgs2, Steap4, and Nos2, while having no impact 
on the expression of antioxidant genes.  
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It is unclear whether one or several of the identified JUND targets contribute to its 
effect on oxidative stress and apoptosis in β cells. Interestingly, both Ptgs2 and 
Steap4 are upregulated in islets from db/db mice and have some genetic 
association with T2D in humans (Konheim and Wolford, 2003; Sharma et al., 
2015). Ptgs2, which encodes cyclooxygenase-2 (COX-2), imparts deleterious 
effects in β cells, including impaired insulin secretion, reduced cell proliferation, 
and increased free radical levels (Oshima et al., 2006; Persaud et al., 2007; 
Tabatabaie et al., 2003). Steap4 encodes a metalloreductase involved in iron and 
copper reduction (Scarl et al., 2017). While Steap4-/- mice develop hyperglycemia 
likely due to adipose inflammation and insulin resistance (Wellen et al., 2007), its 
function in β cells is unknown. In osteoclast differentiation and prostate 
carcinogenesis, however, increased STEAP4 levels cause an elevation in cellular 
ROS (Jin et al., 2015; Zhou et al., 2013a). Further, Nos2, or inducible nitric oxide 
synthase (iNOS), has strong connections to cytokine-mediated β cell dysfunction 
and death (Zumsteg et al., 2000).  
Several other genes downregulated by JUND depletion are implicated in islet 
inflammation, including Ccl2, Cxcl1, and Cxcl2, which have been linked to poor 
outcomes for islet transplantation (Citro et al., 2012; Piemonti et al., 2002). Thus, 
targeting JUND provides a new avenue for dampening oxidative stress and 
inflammation in islets, which warrants further investigation for clinical applications 
such as diabetes therapy and islet transplantation. 
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The connection between these JUND target genes and β cell demise strengthens 
our finding that JUND induction during glucolipotoxicity is maladaptive. Although 
we initially expected the opposite outcome, the data presented here consistently 
support this model. Furthermore, the significant overlap between JUND targets 
and genes upregulated in islets from db/db mice indicates that the regulation of 
these genes is relevant for in vivo stress conditions and is not an artifact of 
culturing conditions. To follow-up on these studies, it would be ideal to 
conditionally ablate JUND in β cell in vivo. However, this mouse model will need 
to be carefully designed to avoid disrupting regulatory elements with loxP sites 
since JUND is an intronless gene.  
The discrepancy between JUND’s effect on oxidative stress in β cells compared 
to endothelial cells or fibroblasts suggests that its interacting factors may also be 
distinct between these cell types. The precise interacting factors that give rise to 
these opposite phenotypes are currently unclear. Given the broad array of 
hetero-dimers that can be formed with JUND, it may be difficult to pinpoint 
exactly which combinations give rise to pro-oxidant or anti-oxidant effects.  
The reported interaction between JUND and MENIN also raises the interesting 
possibility that JUND could impact β cell proliferation (Agarwal et al., 1999). We 
did not find any evidence that loss of JUND impacted cell cycle progression 
based on our RNA-seq results. However, we did not directly assess proliferation 
in our experiments. It should also be noted that the RNA-seq was performed in 
Min6 cells, which are constantly in a proliferative state. Finally, JUND may 
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regulate β cell proliferation only in the context of stress or particular 
environmental conditions. Therefore, a closer examination of the impact of JUND 
on β cell proliferation in primary islets, or ideally in vivo, is warranted. 
Our results show for the first time that translational induction of JUND occurs in β 
cells during metabolic stress conditions. To assess the conservation of this 
finding in humans, we have shown a significant increase in JUND levels in 
human islets cultured with high glucose and free fatty acid levels. This finding, 
combined with the significant overlap between JunD targets and genes 
upregulated during treatment of human islets with palmitate, indicates that JUND 
induction is pertinent to the β cell response to metabolic stress in humans. To 
expand on these findings, it would be interesting to examine whether there is an 
increase in JUND levels in islets from individuals with T2D by 
immunofluorescence staining. Given that the induction of JUND during in vitro 
stress conditions is 2-3 fold and that there is typically high variability between 
human samples, however, it may be difficult to confidently discern an increase in 
JUND levels using this approach.  
Given its effects on cell survival and oxidative stress, we propose a maladaptive 
role for JUND in β cells under metabolic stress. These findings are based on 
culturing islets under high glucose and palmitate levels comparable to that which 
would be seen in late stages of T2D. Similarly, the in vivo assessment of JUND 
induction utilized the db/db model at a stage of severe hyperglycemia. This is 
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consistent with the notion that β cell apoptosis contributes to the worsening of 
hyperglycemia at later stages of T2D rather than at the onset of the disease 
(Prentki and Nolan, 2006). It is currently unclear whether JUND also influences β 
cell function under milder stress conditions that would occur at earlier stages of 
T2D.  
Furthermore, one may contemplate why this maladaptive response occurs in β 
cells under metabolic stress conditions. It is possible that this response is 
adaptive under certain situations and becomes inappropriately activated under 
prolonged disease conditions. Such a notion is particularly relevant for the 
generation of ROS in cells. At low doses, ROS can act as critical signaling 
molecules influencing a wide range of cellular processes, including insulin 
secretion (Pi et al., 2007; Ray et al., 2012). When ROS accumulation becomes 
excessive, however, these molecules become damaging. This imbalance, which 
is the cause of oxidative stress, leads to impaired insulin secretion and increased 
apoptosis in β cells (Poitout and Robertson, 2008). As such, it is possible that 
JUND induction in the acute setting leads to constructive ROS generation and 
activation of adaptive signaling pathways, whereas chronically it promotes β cell 
demise. 
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CHAPTER 4: AN ERK/HNRNPK/DDX3X AXIS POST-TRANSCRIPTIONALLY 
REGULATES JUND DURING METABOLIC STRESS 
4.1  Summary 
Translational regulation is a critical component of stress responses, however, the 
mechanisms controlling this process in pancreatic β cells during 
pathophysiologically-relevant conditions are poorly understood. Here we show 
that the translational induction of JUND during metabolic stress requires the RNA 
binding protein hnRNPK. Furthermore, activation of the MEK/ERK signaling 
pathway is both necessary and sufficient for phosphorylation of hnRNPK and 
induction of JUND during glucolipotoxicity. Consistent with the effect of JUND on 
β cell apoptosis, MEK inhibition significantly reduced cell death in mouse islets 
during metabolic stress. The translational upregulation of JUND could not be 
attributed to a change in hnRNPK subcellular localization, RNA binding affinity, or 
nuclear retention of mRNA. Rather, we found that efficient JUND translation is 
dependent on the RNA helicase DDX3X, an hnRNPK-interacting factor. During 
glucolipotoxicity, there is increased interaction between DDX3X and the 
translation pre-initiation complex (PIC), and this interaction is abrogated with loss 
of hnRNPK. Thus, hnRNPK regulates JUND translation in part by facilitating the 
recruitment of the PIC via DDX3X.	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4.2  Introduction 
In order to adapt to stress conditions imposed by changes in the extracellular 
environment, β cells must dynamically shift their gene expression profile. This 
allows for the synthesis of proteins that promote restoration of cellular 
homeostasis and recovery from stress. On the other hand, changes in gene 
expression can be maladaptive during disease states and exacerbate cellular 
dysfunction. Therefore, the identification of factors that shape the β cell response 
to stress conditions is a critical step towards better understanding the 
mechanisms of β cell failure in T2D. In the previous chapters, we used a 
translation-centric approach to uncover the transcription factor JUND as part of a 
β cell maladaptive response to high levels of glucose and free fatty acids, 
conditions relevant for T2D pathophysiology. Thus, understanding the 
mechanisms controlling JUND translation during stress could provide novel 
therapeutic strategies to modulate redox balance in β cells. 
Translational regulation of specific mRNAs is dependent on the presence of 
regulatory elements, typically in the 5’ or 3’ UTRs, which permit targeting by 
sequence-specific factors, including microRNAs and RNA binding proteins 
(RBPs). The enrichment of a poly(C) motif in genes from our TRAP screen 
suggested this element may impart translational control mediated by the poly(C)-
binding protein family of RBPs.  
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The PCBP family consists of five members (PCBP1-4 and hnRNPK), which play 
diverse roles in gene regulation, including regulation of transcription, splicing, 
alternative polyadenylation, mRNA stability, and translation (Bomsztyk et al., 
2004; Ji et al., 2013; 2016; Makeyev and Liebhaber, 2002; Ostareck-Lederer et 
al., 2002; Waggoner et al., 2009). This diversity of function allows the PCBPs to 
affect a broad array of cellular processes, including apoptosis, cell cycle 
progression, cellular differentiation, etc. (Makeyev and Liebhaber, 2002; 
Ostareck-Lederer and Ostareck, 2012; Waggoner et al., 2009). While the 
members PCBP1-2 and hnRNPK are broadly expressed across cell types, they 
may have cell-type specific effects based on the expression patterns of cofactors 
and target mRNAs. Furthermore, a common mechanism for the functional 
regulation of this family of RBPs is post-translational modification via 
phosphorylation (Bomsztyk et al., 2004; Chaudhury et al., 2010b; Kimura et al., 
2010). This allows for the rapid integration of various signaling pathways with 
multiple steps of gene expression. Thus, the PCBPs are fascinating candidates 
for shaping the β cell gene expression profile in response to various stimuli and 
stressors. Given their diversity of action, this regulation may be complex but 
nevertheless deserves further scrutiny to uncover novel aspects of β cell biology.  
In this chapter, we focus on the role of hnRNPK in regulating JUND translation in 
β cells, leading to the identification of an ERK/hnRNPK/DDX3X pathway that is 
activated during metabolic stress. 
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4.3  Materials and Methods 
Cell line culture 
Min6 mouse insulinoma cells passage 20-30 were cultured in high glucose 
DMEM as described (Claiborn et al., 2010), unless otherwise noted. For lentiviral 
infections, Min6 cells were transduced for 6 hours with virus and polybrene 
(Sigma) at 8ug/mL. Cells were allowed to recover for 4-5 days before collection 
or stress treatments. HEK293T cells were cultured in DMEM containing 25mM 
glucose. 
Western blot 
Proteins were separated by SDS-PAGE and immunoblotted with the following 
antibodies: rabbit anti-JUND (Santa Cruz, sc-74), rabbit anti-hnRNPK (Bethyl 
Laboratories, A300-674A), rabbit anti-DDX3X (Bethyl Laboratories, A300-474A), 
rabbit anti-phospho-ERK1/2 (Cell Signaling, 4377), rabbit anti-total-ERK1/2 (Cell 
Signaling, 4695), mouse anti-Tubulin (Sigma, T9026), and mouse anti-Ran (B.D. 
610340). 
Co-immunoprecipitation 
Min6 cells were lysed in buffer containing 20mM Tris pH 8.0, 137 mM NaCl, 1mM 
MgCl2, 1mM CaCl2, 1% NP-40, 10% glycerol, protease inhibitor cocktail 
(Millipore), and Benzonase (Sigma) at 12.5 U/mL. Lysates were rotated at 4°C 
for 1 hour. Protein concentration was determined using a Micro BCA Protein 
Assay Kit (Thermo). 1ug of primary antibody was added to lysate encompassing 
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500ug of protein and incubated overnight at 4°C.  Protein A Dynabeads were 
washed 3 times in lysis buffer then resuspended in lysate/antibody mixture and 
incubated for 3 hours at 4°C. The immunoprecipitations were washed 4 times 
with lysis buffer then eluted in NuPAGE LDS Sample Buffer (Invitrogen) by 
heating at 70°C for 10 minutes. Eluted proteins and input samples were analyzed 
by western blot. 
Phos-tag analysis 
Phos-tag was performed as described (Kinoshita et al., 2006). Briefly, lysates 
were run on SDS-PAGE gels containing 25uM Phos-tag acrylamide (Wako), 
50uM MnCl2, and 8% acrylamide. The gels were run for 4hrs at 90V to achieve 
optimal separation of bands for hnRNPK. Prior to transfer, the gels were soaked 
in buffer containing 10mM EDTA for 1 hour. 
RNA immunoprecipitation 
RNA immunoprecipitation was performed using rabbit anti-hnRNPK (Bethyl 
Laboratories, A300-674A) or rabbit anti-DDX3X antibodies (Bethyl Laboratories, 
A300-474A). hnRNPK or DDX3X antibodies or IgG were bound to Protein A 
Dynabeads in buffer containing 20mM HEPES pH 7.4, 5mM MgCl2, 150mM KCl, 
2mM DTT, 1% NP-40. Min6 cells were lysed in buffer containing 50mM Tris pH 
8.0, 150mM NaCl, and 1% NP-40 with RNase, protease, and phosphatase 
inhibitors. Total RNA was extracted from lysate (10% input) using RNeasy Mini 
Kit (Qiagen). Lysate encompassing 75ug or 200ug of protein was added to beads 
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bound to antibody for hnRNPK or DDX3X, respectively, and an IgG control, then 
incubated overnight at 4°C. The next day, IPs were washed with buffer 
containing 20mM HEPES pH 7.4, 5mM MgCl2, 350mM KCl, 2mM DTT, 1% NP-
40, and RNase inhibitors. RNA was eluted from beads in RLT buffer (Qiagen) 
and RNA was isolated using RNeasy Mini Kit (Qiagen). For RIP followed by RT-
qPCR, enrichment was calculated by first normalizing transcript abundance in IP 
RNA to that in total RNA and then to the IgG control. 
CRISPR design and cloning 
CRISPR gRNAs were designed using http://crispr.mit.edu/ to minimize off-target 
binding (ROSA26: AAGATGGGCGGGAGTCTTCT, hnRNPK: 
GTTTAATACTTACGTCTGTA, DHX9: TTCAGTTGTGATTATCCGAG and 
GAGCGAGTTGCTTATGAGAG, DDX1: CAGATGAACCCATATGATAG and 
GGAACTAGAGGACTGCTGAA, DDX3X: AGATTGGATACTGTTTACGA and 
GCACCACCATAAACCACGCA). gRNAs were cloned into lentiCRISPR v2, as 
described (Sanjana et al., 2014). 
MEK1-CA Cloning 
Constitutively active MEK1 fragments were generated by PCR with primers to 
introduce S->D mutations at Ser218 and Ser222. CA-MEK1 and the rat insulin 
promoter fragments were cloned into pLenti CMV blast (Campeau et al., 2009) 
using Gibson Assembly (replaced CMV promoter with RIP). 
Immunofluorescence staining of Min6 cells  
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Min6 cells were cultured in 4-well chamber slides. After culturing under desired 
conditions, cells were washed in PBS, and fixed for 15 minutes at room 
temperature in 4% PFA. Following permeabilization (0.1% Triton x-100 for 10 min 
at room temperature), immunofluorescence staining was performed using the 
following antibodies: guinea pig anti-insulin (Dako, A0564) and goat anti-GFP 
(Abcam, 6673). Images were taken on a Keyence BZ-X700 microscope and 
images were analyzed using the BZ-X Advanced Analysis Software. 
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4.4  Results 
4.4.1  hnRNPK is required for the translational induction of JUND during 
metabolic stress 
Despite binding to its mRNA, loss of hnRNPK had no impact on JUND levels 
under baseline conditions (Figures 2.4 and 2.6). Instead, we hypothesized that 
hnRNPK controls the induction of JUND during metabolic stress. To assess this 
possibility, we used CRISPR-Cas9 to deplete hnRNPK in Min6 cells followed by 
treatment with high levels of palmitate. While control cells receiving a ROSA26 
gRNA demonstrated the expected upregulation of JUND, depletion of hnRNPK 
completely blocked this induction despite having no impact on JUND mRNA 
abundance (Figure 4.1a,b). To confirm the specificity of this effect, we performed 
a knockout/rescue experiment for hnRNPK in Min6 cells. The gRNA targeting 
hnRNPK spans an intron-exon junction and thus should not affect vector-
mediated expression of hnRNPK due to the absence of introns. Indeed, 
expression of hnRNPK from a lentiviral construct restored its expression in the 
presence of the targeting gRNA (Figure 4.1c). While loss of hnRNPK prevented 
JUND induction during glucolipotoxicity, re-expression of hnRNPK rescued this 
effect comparable to the ROSA26 control group (Figure 4.1c). This indicates that 
the impact of hnRNPK on JUND induction is not due to an off-target effect of 
CRISPR editing. Thus, hnRNPK binds to the JUND mRNA and is required for its 
post-transcriptional induction during metabolic stress. 
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Figure 4.1. CRISPR-mediated depletion of hnRNPK blocks JUND induction during 
glucolipotoxicity. 
a, Western blot and quantification showing depletion of hnRNPK in Min6 cells using CRISPR-
Cas9 and its impact on the induction of JUND after 2 days of palmitate treatment (n=6). b, No 
change in JUND transcript levels with depletion of hnRNPK in Min6 cells during palmitate 
treatment, as determined by RT-qpCR (n=6). c, Western blot and quantification showing 
depletion of hnRNPK in Min6 cells using CRISPR-Cas9 and rescue with a vector to overexpress 
hnRNPK. Cells were treated for 30hrs in control (Cont) or glucolipotoxic (GLT) conditions (n=2).  
P values were calculated by two-way ANOVA (a) or unpaired two-tailed Student’s t-test (b). For 
Western blot images of JUND, arrows denote two bands for JUND and * denotes a non-specific 
band. Otherwise, * = p < 0.05. 
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4.4.2  hnRNPK is phosphorylated during metabolic stress in a MEK-
dependent manner 
A common mechanism for regulation of hnRNPK function is post-translational 
modification via phosphorylation (Bomsztyk et al., 2004). To study changes in 
hnRNPK phosphorylation, we used Phos-tag SDS-PAGE, which unveils 
phosphorylated forms of hnRNPK via electrophoresis (Kimura et al., 2010). This 
approach clearly demonstrated a shift towards increased phosphorylation of 
hnRNPK in mouse islets or Min6 cells exposed to high levels of glucose and 
palmitate while total hnRNPK levels did not change (Figure 4.2a,b). This increase 
in phosphorylation was specific for metabolic stress, as it did not occur during 
stress induced by hydrogen peroxide or thapsigargin, paralleling the pattern of 
JUND induction (Figure 4.2c). Similarly, there was an increase in hnRNPK 
phosphorylation in isolated islets from diabetic db/db mice, indicating that this 
pathway is also activated during metabolic stress in vivo (Figure 4.2d). To assess 
hnRNPK phosphorylation in a human model, we cultured human islets in 
glucolipotoxic conditions and observed a significant increase in hnRNPK 
phosphorylation by Phos-tag and no change in total hnRNPK levels (Figure 
4.2e). 
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Figure 4.2. Increased phosphorylation of hnRNPK during metabolic stress. 
a, Phos-tag SDS-PAGE analysis shows changes in phosphorylation of hnRNPK in mouse islets 
treated with glucolipotoxic (GLT) conditions for 2 days (n=5). b, Phos-tag SDS-PAGE and 
Western blot showing increased phosphorylation of hnRNPK in Min6 cells treated with increasing 
doses of palmitate for 2 days (n=3). c, Phos-tag for hnRNPK showing changes in phosphorylation 
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in mouse islets treated with a panel of stressors including hydrogen peroxide (H2O2, 200uM) for 1 
hr, GLT for 2 days, or thapsigargin (Tg, 1uM) for 3 hrs (n=3). d, Phos-tag SDS-PAGE analysis 
shows changes in phosphorylation of hnRNPK in islets from 12-wk old db/db or db/+ male mice 
(n=3). e, Phos-tag SDS-PAGE analysis shows changes in phosphorylation of hnRNPK in human 
islets treated with glucolipotoxic (GLT) conditions for 2 days (n=3). np denotes band for non-
phosphorylated hnRNPK and ph denotes bands for phosphorylated hnRNPK. P values were 
calculated by unpaired two-tailed Student’s t-test. For Western blot images of JUND, arrows 
denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 0.05. 
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To assess whether this increase in phosphorylation is unique to hnRNPK or 
common amongst PCBP family members, we performed Phos-tag analysis for 
PCBP1 and PCBP2 in Min6 cells exposed to metabolic stress conditions. 
Compared to analysis using standard SDS-PAGE, Phos-tag revealed additional 
bands for PCPB1 and PCBP2 correlating to phosphorylated forms of these 
proteins (Figure 4.3). However, unlike hnRNPK, there was no obvious change in 
the relative pattern nor intensity of these bands in Min6 cells exposed to high 
palmitate levels (Figure 4.3). This suggests that the increase in phosphorylation 
during metabolic stress is unique to hnRNPK and does not occur for PCBP1/2. 
However, Phos-tag analyses may not resolve all phosphorylated sites of a 
particular protein (Kinoshita et al., 2008), thus we cannot rule out the possibility 
that there is an increase in phosphorylation of PCBP1/2 at a site that cannot be 
identified by Phos-tag.  
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Figure 4.3. No change in phosphorylation of PCBP1/2 during metabolic stress as detected 
by Phos-tag analysis. 
Phos-tag SDS-PAGE and Western blot showing no change in phosphorylation or total protein 
levels of PCBP1/2 in Min6 cells treated with indicated concentration of palmitate for 24 hours 
(n=3).  
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One of the kinase cascades that targets hnRNPK and modulates its function is 
the MEK/ERK signaling pathway (Habelhah et al., 2001), which was activated in 
mouse islets treated with high levels of glucose and palmitate (Figure 4.4a). 
Treatment of mouse islets with the potent and specific MEK1/2 inhibitor 
trametinib during metabolic stress completely abolished p-ERK1/2 levels while 
also blocking the increase in phosphorylation of hnRNPK and the induction of 
JUND (Figure 4.4a). Trametinib treatment also reduced expression levels of most 
JUND target genes in mouse islets, including Ptgs2 and Steap4 (Figure 4.4b). To 
test the sufficiency of ERK to activate the hnRNPK/JUND axis, we 
overexpressed a constitutively active form of MEK1 (S218/222D) in Min6 cells. 
As expected, this led to a robust increase in phosphorylation of ERK1/2 (Figure 
4.5a). Consistent with the effect of MEK inhibition, expression of constitutively 
active MEK1 was sufficient to increase JUND levels, hnRNPK phosphorylation, 
and expression of many JUND targets, most notably Ptgs2 (Figure 4.5a,b). To 
test whether blocking the hnRNPK/JUND axis via MEK inhibition would also 
reduce apoptosis, we assessed caspase activation in mouse islets treated with 
trametinib and found a striking decrease in apoptosis during metabolic stress 
(Figure 4.6). 
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Figure 4.4. MEK inhibition blocks hnRNPK phosphorylation and JUND induction during 
metabolic stress. 
a,b Western blot, Phos-tag SDS-PAGE (a), and RT-qPCR (b) analyses show that trametinib 
treatment (1uM) blocks ERK phosphorylation and activation of the hnRNPK/JUND axis in mouse 
islets cultured for 2 days in glucolipotoxic (GLT) or control conditions. Quantification is the 
average of 4 (a) or 3 (b) biological replicates. * = p < 0.05. P values were calculated by two-way 
ANOVA (a) or unpaired two-tailed Student’s t-test (b). For Western blot images of JUND, arrows 
denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 0.05. 
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Figure 4.5. Overexpression of constitutively active MEK1 in Min6 cells is sufficient to 
activate the hnRNPK/JUND axis. 
a,b Lentiviral overexpression of constitutively active (CA) MEK1 (S218/222D) in Min6 cells 
activates the ERK/hnRNPK/JUND pathway as determined by Western blot and Phos-tag SDS-
PAGE (a) or RT-qPCR (b) (n=3). EV denotes lentiviral transduction with empty vector. * = p < 
0.05. P values were calculated by unpaired two-tailed Student’s t-test. For Western blot images of 
JUND, arrows denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 
0.05. 
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Figure 4.6. MEK inhibition reduces islet cell apoptosis during glucolipotoxicity. 
Trametinib treatment (1uM) reduces the percentage of apoptotic cells, as determined by 
fluorescence imaging of FLICA reagent, in mouse islets cultured for 3 days in GLT conditions 
(n=3). * = p < 0.05. P values were calculated by two-way ANOVA. 
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4.4.3  No change in hnRNPK localization, RNA binding affinity, or nuclear 
retention of RNA during metabolic stress 
To further investigate how hnRNPK may impact JUND translation during 
metabolic stress, we considered several possible mechanisms based on 
modifiable properties of hnRNPK. For example, hnRNPK is a nucleo-cytoplasmic 
shuttling protein and its subcellular distribution can vary amongst cell types 
(Bomsztyk et al., 2004). Furthermore, this property of hnRNPK is dynamic and 
can be modified by its phosphorylation state. Indeed, it has been reported that 
phosphorylation of hnRNPK by ERK leads to its cytoplasmic accumulation in 
HeLa cells (Habelhah et al., 2001). To assess whether phosphorylation of 
hnRNPK during glucolipotoxicity also influenced the subcellular distribution of 
hnRNPK, we performed immunofluorescence staining of Min6 cells. First, we 
confirmed the specificity of the hnRNPK antibody in immunostaining analyses by 
showing that CRISPR-mediated depletion of hnRNPK in Min6 cells leads to the 
complete loss of the immunofluorescence signal in the targeted cells (Figure 
4.7a). Next, we assessed the subcellular localization of hnRNPK in Min6 cells 
treated with glucolipotoxicity and observed no change in its distribution compared 
to control conditions (Figure 4.7b). Given the reported connection between 
hnRNPK localization and ERK signaling, we further investigated this possibility 
by using overexpression of constitutively active MEK1, which leads to robust 
phosphorylation of ERK1/2 (Figure 4.5). In contrast to previous reports, 
expression of constitutively active MEK1 had no impact on hnRNPK subcellular 
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distribution (Figure 4.7c). Together, these results indicate that the impact of 
hnRNPK on JUND translation during glucolipotoxicity cannot be explained by a 
change in its nucleo-cytoplasmic shuttling.  
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Figure 4.7. No change in hnRNPK subcellular distribution in Min6 cells during metabolic 
stress. 
a, Representative immunofluorescence images of fixed Min6 cells with CRISPR-mediated 
depletion of hnRNPK in a subset of cells to confirm the specificity of the hnRNPK antibody. A 
gRNA targeting the ROSA26 locus was used as a negative control. b,c, Representative 
immunofluorescence images of fixed Min6 cells that were treated with control or glucolipotoxic 
conditions for 30hrs (b) or transduced with lentivirus to overexpress constitutively active MEK1 
(CA-MEK1) (c), which show no detectable change in the subcellular localization of hnRNPK 
under these conditions. 
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Another modifiable property of hnRNPK is its RNA binding affinity. For example, 
treatment of a rat hepatoma cell line with insulin led to phosphorylation of 
hnRNPK, and this increased the binding affinity of hnRNPK for RNA containing 
poly(C) stretches (Ostrowski et al., 2001). Therefore, we hypothesized that 
phosphorylation of hnRNPK during glucolipotoxicity affected JUND translation by 
increasing the interaction between hnRNPK and the mRNA encoding JUND. To 
assess this possibility, we performed RNA immunoprecipitation for hnRNPK in 
Min6 cells treated with control or glucolipotoxic conditions. This showed that 
there was no change in the amount of JUND mRNA pulled down with hnRNPK in 
the RIP experiment, suggesting that a change in hnRNPK binding to JUND 
mRNA cannot explain its effect on translation (Figure 4.8a). 
The export of mRNA from the nucleus to the cytoplasm can be regulated to 
provide an additional post-transcriptional control on gene expression. In fact, 
some mRNAs are preferentially retained in the nucleus, and this has recently 
been attributed at least in part to targeting by hnRNPK (Lubelsky and Ulitsky, 
2018). Therefore, we next considered the possibility that hnRNPK regulates the 
nuclear retention of JUND mRNA in a stress-dependent manner. To address this, 
we first investigated whether there is a shift in the nucleo-cytoplasmic localization 
of the JUND mRNA during metabolic stress. We performed fractionation 
experiments in Min6 cells to enrich for nuclear and cytoplasmic compartments 
and isolated RNA from these pools. To validate our methodology of fractionation, 
we assessed the nuclear/cytoplasmic distribution of genes with known 
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localization patterns. For example, mRNAs encoding housekeeping factors, such 
as HPRT and BETA-ACTIN are highly translated and should be predominantly 
cytoplasmic. In agreement with this, approximately 80% of the mRNA for these 
genes was located in the cytoplasmic fraction (Figure 4.8b). On the other hand, 
NEAT1 is a nuclear enriched long non-coding RNA, and accordingly 90% of its 
mRNA was present in the nuclear fraction. As an additional nuclear control, we 
used primers spanning an intron-exon junction for PDX1 to detect its primary 
transcript, which should be found in the nucleus. Indeed, 85% of this mRNA was 
located in the nuclear compartment. Assessment of JUND mRNA showed that is 
was predominantly located in the cytoplasm, and there was no change in its 
localization during glucolipotoxicity (Figure 4.8b). Thus, a shift in the nucleo-
cytoplasmic distribution of the JUND mRNA cannot explain its induction during 
metabolic stress. 
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Figure 4.8. No change in hnRNPK RNA binding affinity or nuclear retention of mRNA 
during metabolic stress. 
a, No change in the interaction of hnRNPK with the mRNA encoding JUND in Min6 cells after 
30hrs treatment with glucolipotoxicity (GLT), as determined by RNA immunoprecipitation (n=4). b, 
Fractionation of Min6 cells into nuclear and cytoplasmic pools followed by RT-qPCR analysis 
shows no change in the subcellular localization of the JUND mRNA after culturing for 30hrs in 
GLT conditions (n=2). Transcript level in the cytoplasmic fraction was normalized to the combined 
transcript level in the cytoplasmic and nuclear fractions to determine the fraction of mRNA in the 
cytoplasm. HPRT and BETA-ACTIN were used as controls for cytoplasmic enriched RNA while 
NEAT1 and PDX1 primary transcript (PT) were used as controls for nuclear enriched RNA to 
assess fractionation quality. P values were calculated by unpaired two-tailed Student’s t-test. 
Cont denotes control culturing conditions and GLT denotes glucolipotoxic culturing conditions.  
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4.4.4  DDX3X interacts with hnRNPK and is required for efficient translation 
of JUND mRNA 
Since we were unable to detect a change in some of the known modifiable 
properties of hnRNPK during metabolic stress (Figures 4.7 and 4.8), we 
hypothesized that hnRNPK impacts JUND translation via a binding partner. The 
JUND mRNA contains a highly structured 5’UTR (Short and Pfarr, 2002), and 
efficient translation initiation is dependent on RNA helicases, such as DHX9, to 
resolve these secondary structures (Hartman et al., 2006). Upon searching mass 
spectrometry data sets for hnRNPK interacting factors (Chen et al., 2002; Mikula 
et al., 2015), we noticed the presence of the DEAD-box helicases DHX9, DDX1, 
and DDX3X in the hnRNPK interactome. Given the connection of DEAD-box 
helicases to the regulation of translation (Hartman et al., 2006; Linder and 
Jankowsky, 2011), we depleted these genes in Min6 cells via CRISPR-Cas9 to 
determine their impact on JUND induction during metabolic stress (Figure 
4.9a,b). Interestingly, loss of DDX3X, but not DHX9 nor DDX1, led to reduced 
JUND protein levels in Min6 cells during glucolipotoxicity (Figure 4.9c). On the 
other hand, loss of DDX3X also led to a significant increase in JUND mRNA 
levels (Figure 4.9d). This decrease in the amount of JUND protein despite an 
increase in mRNA abundance likely signifies a defect in translation initiation 
caused by loss of DDX3X, consistent with its ability to enhance translation of 
select mRNAs (Soto-Rifo et al., 2012). Indeed, depletion of DDX3X in GFP-
RPL10A Min6 cells led to a significant reduction in the density of ribosomes 
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binding to the JUND mRNA, as determined by TRAP (Figure 4.9e). These data 
indicate that DDX3X is required for the efficient translation of JUND mRNA. 
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Figure 4.9. DDX3X is required for the efficient translation of JUND mRNA. 
a,b RT-qPCR for DHX9, DDX1, and DDX3X (a) and Western blot for DDX3X (b) show a 
significant depletion of these RNA helicases using CRISPR-Cas9 in Min6 cells (n=3). c, 
Representative western blot depicting JUND levels in Min6 cells transduced with lentivirus to 
deplete the indicated RNA helicase using CRISPR-Cas9 and cultured in glucolipotoxic conditions 
for 30hrs (n=3). d, Assessment of JUND mRNA abundance in Min6 cells by RT-qPCR after 
CRISPR-mediated depletion of DDX3X and culturing in glucolipotoxic conditions for 30hrs (n=3). 
e, Decreased ribosome occupancy of JUND in GFP-RPL10a Min6 cells after depletion of DDX3X 
by CRISPR-Cas9 and 30 hours of glucolipotoxic conditions, as determined by TRAP followed by 
RT-qPCR (n=3). * = p < 0.05 and ns = not significant. P values were calculated by two-way 
ANOVA except in (b) in which an unpaired two-tailed Student’s t-tests was used. In (d) * denotes 
significance compared to ROSA26 group of the same treatment. For Western blot images of 
JUND, arrows denote two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 
0.05.  
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To assess the interaction between hnRNPK and DDX3X, we performed co-
immunoprecipitation experiments in Min6 cells in the presence of a nuclease to 
degrade both RNA and DNA. This showed a clear nucleic acid-independent 
interaction between these two factors that was maintained during 
glucolipotoxicity (Figure 4-10a). DDX3X and its yeast homolog Ded1 can impact 
translation through interaction with components of the translation pre-initiation 
complex (PIC), especially the 18S ribosomal RNA (Guenther et al., 2018; Oh et 
al., 2016). Indeed, RIP for DDX3X showed a robust binding to 18S in Min6 cells, 
and this interaction was increased during metabolic stress (Figure 4-10b). 
Intriguingly, CRISPR-mediated depletion of hnRNPK in Min6 cells significantly 
reduced the association between DDX3X and 18S (Figure 4-10c). DDX3X has 
been reported to bind to all expressed mRNAs, likely via its interaction with the 
PIC (Guenther et al., 2018; Oh et al., 2016). Consistent with this, DDX3X bound 
to all analyzed mRNAs by RIP, and these interactions were significantly reduced 
with loss of hnRNPK (Figure 4-10d). These data support a model whereby 
hnRNPK impacts translation in part by promoting the interaction between DDX3X 
and the PIC. Thus, we have identified DDX3X as a novel regulator of JUND 
translation during metabolic stress that interacts with the 18S ribosomal RNA in 
an hnRNPK-dependent manner.  
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Figure 4.10. DDX3X interacts with the 18S ribosomal RNA in an hnRNPK-dependent 
manner. 
a, Western blots from pull-down of hnRNPK (left) or DDX3X (right) in Min6 cells treated with 
glucolipotoxic conditions for 30 hrs. b,c RNA immunoprecipitation for DDX3X followed by RT-
qPCR for 18S ribosomal RNA in Min6 cells treated with glucolipotoxic conditions for 30hrs (n=3) 
(b) and in Min6 cells with CRISPR-mediated depletion of hnRNPK and cultured in glucolipotoxic 
conditions for 30hrs (n=3) (c). d, Decreased interaction between DDX3X and indicated mRNAs 
after CRISPR-mediated depletion of hnRNPK in Min6 cells treated with glucolipotoxic conditions 
for 30hrs as determined by RNA immunoprecipitation for DDX3X (n=3). * = p < 0.05 and ns = not 
significant. P values were calculated by two-way ANOVA except in (b) in which unpaired two-
tailed Student’s t-tests were used. In (c,d), * denotes significance compared to ROSA26 group of 
the same treatment unless otherwise noted. For Western blot images of JUND, arrows denote 
two bands for JUND and * denotes a non-specific band. Otherwise, * = p < 0.05.  
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4.5  Discussion 
Although the transcriptional regulators that shape the proper β cell gene 
expression program have received much attention, the factors important for post-
transcriptional regulation in β cells, such as RBPs, are less defined but may be 
critical for adaptation to environmental stressors. Here, an unbiased search for 
putative regulatory motifs led to the identification of hnRNPK as a post-
transcriptional regulator of JUND expression. While we implicate hnRNPK as a 
regulator of translation in β cells, its highly multi-functional nature suggests it 
likely serves other roles as well, such as regulating transcription, splicing, and 
mRNA stability (Bomsztyk et al., 2004). This versatility is intriguing in that 
hnRNPK can integrate signaling pathways with multiple aspects of RNA 
processing, but it also complicates the design and interpretation of loss-of-
function studies. Nevertheless, given its activation during metabolic stress in 
vivo, a systematic analysis of hnRNPK function holds promise to elucidate novel 
aspects of β cell biology. By focusing on hnRNPK interacting factors, we 
identified the RNA helicase DDX3X as a novel hnRNPK partner that participates 
in the regulation of JUND translation. While the function of DDX3X in β cells is 
unknown, its links to cell cycle progression, apoptosis, and innate immunity in 
other cell types (Ariumi, 2014) warrant a broader examination of DDX3X function 
in β cells.  
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hnRNPK can be phosphorylated downstream of multiple signaling pathways, 
including Protein kinase C, JNK, and ERK (Habelhah et al., 2001; Schullery et 
al., 1999). In β cells, we have found that activation of the MEK/ERK signaling 
pathway is both necessary and sufficient to increase hnRNPK phosphorylation 
and induce JUND levels (Figure 4.11). Furthermore, in the context of metabolic 
stress, inhibition of this ERK/hnRNPK/JUND axis with trametinib reduced 
apoptosis in mouse islets. This is consistent with previous findings that MEK 
inhibition reduced apoptosis in human islets treated with high glucose levels or 
IL-1β (Maedler et al., 2004). In contrast, activation of the MEK/ERK signaling 
pathway has been shown to promote β cell survival in the context of incretin 
signaling (Campbell et al., 2016; Quoyer et al., 2010). Thus, the impact of MEK 
inhibition on β cell viability is context-dependent. Interestingly, treatment of ob/ob 
mice with trametinib improves glucose homeostasis in these animals, however, 
this effect appears to be largely attributable to an improvement in insulin 
sensitivity (Banks et al., 2015). Thus, the use of MEK inhibition in metabolic 
syndrome warrants further investigation for improving both insulin sensitivity and 
β cell viability. 
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Figure 4.11. Model diagram depicting an ERK/hnRNPK/JUND axis that promotes oxidative 
stress and apoptosis in β cells. 
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To advance our understanding of translational regulation mediated by hnRNPK, 
we systematically evaluated modifiable properties of hnRNPK during metabolic 
stress including its subcellular localization, RNA binding affinity, and nuclear 
retention of mRNA. None of these features, however, could explain the induction 
of JUND during glucolipotoxicity. This led us to consider the possibility that 
hnRNPK regulates translation via a cofactor. To further explore this prospect, we 
utilized published mass spectrometry data sets for hnRNPK interacting factors 
(Chen et al., 2002; Mikula et al., 2015), however, this included nearly 200 
proteins. Accordingly, we focused our search on RNA helicases because JUND 
has been reported to contain a highly structured 5’UTR (Short and Pfarr, 2002), 
which narrowed our search to three candidates: DHX9, DDX1, and DDX3X. 
DHX9 has previously been shown to regulate JUND translation in COS cells 
(Hartman et al., 2006) and it was highly enriched for hnRNPK binding in one 
mass spectrometry data set (Mikula et al., 2015); therefore this target seemed 
particularly promising. Surprisingly, however, depletion of DHX9 had no impact 
on the induction of JUND during glucolipotoxicity or on its expression under 
baseline conditions in Min6 cells. One possibility is that other DEAD-box 
helicases expressed in β cells provide redundancy for DHX9. Indeed, the DEAD-
box protein family contains 37 members in humans, many of which regulate 
translation (Linder and Jankowsky, 2011). 
In contrast to DHX9, loss of DDX3X clearly reduced JUND translation in Min6 
cells based on reductions in both protein levels and ribosome occupancy. In 
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other cell types, DDX3X has been implicated in translational regulation of specific 
mRNAs, such as cyclin E1 (Lai et al., 2010), and several viral genes (ie: HIV, 
Japanese encephalitis virus, etc.) (Soto-Rifo et al., 2012). In Min6 cells, DDX3X 
depletion significantly reduced the ribosome occupancy of JUND, but not BETA-
ACTIN, mRNA, indicating that loss of DDX3X impacts the translation of specific 
genes. In the future, it would be interesting to define the full catalog of DDX3X 
targets in β cells by TRAP-seq. Additionally, we cannot rule out the possibility 
that loss of DDX3X also has an effect on global translation rates, which would not 
be picked up by TRAP analyses.  
We also investigated the mechanism by which DDX3X and hnRNPK may 
cooperate to impact translation. Under metabolic stress, increased 
phosphorylation of hnRNPK does not change its binding to the JUND mRNA. 
Instead, we considered the possibility that phosphorylation of hnRNPK may 
enhance its interaction with DDX3X, thus recruiting the helicase to JUND mRNA 
in a stress-dependent manner. However, co-immunoprecipitation experiments 
showed no change in the interaction between these factors under control versus 
glucolipotoxic conditions (Figure 4.10).  
The mechanisms by which RNA helicases impact translation of specific mRNAs 
include remodeling secondary structures in the 5’UTR and recruitment of the 
translation pre-initiation complex (PIC) (Marintchev, 2013). DDX3X has been 
shown to directly bind to the 18S ribosomal RNA, a component of the PIC (Oh et 
al., 2016). This led us to hypothesize that hnRNPK may impact the interaction 
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between DDX3X and the PIC. Interestingly, during metabolic stress, there was 
increased interaction between DDX3X and the 18S ribosomal RNA, and this 
interaction was significantly reduced in Min6 cells with loss of hnRNPK. This 
suggests that hnRNPK may influence translation in part by facilitating recruitment 
of the PIC via DDX3X. It is unclear how hnRNPK impacts the DDX3X-PIC 
interaction. One possibility is that hnRNPK promotes formation of the complex by 
directly recruiting the PIC in a stress-dependent manner. On the other hand, 
hnRNPK could indirectly facilitate this interaction via assembly of a larger 
complex that includes DDX3X and the PIC, and the composition of this complex 
may be altered during metabolic stress in an hnRNPK- and ERK-dependent 
manner (Figure 4.12). Additionally, this complex may contain cofactors that 
modulate DDX3X activity, as has been reported for EZRIN and GLE1 (Bolger 
and Wente, 2011; Çelik et al., 2015). Thus, it would be interesting to more 
comprehensively define the hnRNPK and DDX3X interactome in β cells under 
control and glucolipotoxic conditions to identify other components of this 
hnRNPK-DDX3X complex, and to determine whether they are recruited in a 
stress-dependent manner.  
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Figure 4.12. Model diagram depicting recruitment of the PIC by an hnRNPK-DDX3X 
complex during metabolic stress. 
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Another mechanistic detail that deserves further elaboration is the localization of 
the DDX3X-hnRNPK complex on mRNA. Our de novo motif analysis and the 
eCLIP data for hnRNPK indicate that it binds to the 3’UTR of the JUND mRNA. 
DDX3X, on the other hand, has been reported to predominantly bind to the 
5’UTR of genes (Oh et al., 2016). Therefore, one possibility is that the interaction 
occurs while DDX3X and hnRNPK are bound to the 5’ and 3’ UTR, respectively, 
thus facilitating circularization of the JUND mRNA (Figure 4.11) similar to that 
mediated by PABP and eIF4G to promote efficient translation initiation 
(Kahvejian et al., 2005). Interestingly, another binding partner for DDX3X is 
PABP (Soto-Rifo et al., 2012), however, it is unclear if this factor is part of the 
hnRNPK-DDX3X complex. Circularization of mRNA has been proposed to 
stimulate ribosome recycling (Dever and Green, 2012), thus it is enticing to 
speculate that hnRNPK could promote the re-assembly of initiation complexes 
after termination. Another possibility is that the hnRNPK-DDX3X interaction 
occurs independent of their respective binding to RNA. In this situation, hnRNPK 
may prime a translation initiation complex by facilitating the interaction between 
DDX3X and the PIC prior to loading onto mRNA. 
Translation initiation can occur independent of binding to the 5’ cap, and this 
mode of translation initiation is particularly important during certain stress 
conditions due to sequestration of eIF4E (Spriggs et al., 2010). It is unclear 
whether translation initiation regulated by the DDX3X-hnRNPK complex can 
occur independent of binding to the 5’ cap. Interestingly, hnRNPK mediates 
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translation initiation at some cellular IRESs, such as in the 5’UTR of c-myc 
(Evans et al., 2003). Similarly, DDX3X is critical for translation initiation at several 
viral IRESs, including that of hepatitis C virus (Geissler et al., 2012). Thus, it will 
be interesting to  examine whether this complex functions during cap-
independent conditions to enhance JUND translation. 
It has recently been shown that loss of Ded1, the yeast homolog of DDX3X, 
promotes alternative start codon usage in the 5’ UTR of certain genes (Guenther 
et al., 2018). Intriguingly, close examination of western blots for JUND indicates 
the appearance of an additional faint band after depletion of DDX3X (Figure 
4.9c). One possibility is that DDX3X prevents the inappropriate translation 
initiation at alternative start codons in the 5’UTR of JUND. The mapping of 
translation initiation sites can be achieved using ribosome profiling after 
treatment of cells with the drug harringtonine to freeze ribosomes at sites of 
initiation (Ingolia et al., 2011). This approach could be used to determine if loss of 
DDX3X dysregulated start codon usage in β cells on a genome-wide scale. This 
would be particularly interesting to assess in β cells because it has been 
suggested that translation from an alternative initiation site in the insulin mRNA 
produces an immunogenic peptide that may contribute to the development of 
type 1 diabetes (Kracht et al., 2017).  
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CHAPTER 5: CONCLUDING REMARKS AND FUTURE DIRECTIONS 
5.1  Discussion of key findings 
The dysfunction and apoptosis of pancreatic β cells are central to the progression 
of T2D, thus identifying new strategies to ameliorate these processes holds 
promise to reduce the burden of this chronic disease. In this work, I have 
approached this goal by first studying the mechanisms underlying β cell 
adaptation to stress conditions that are pertinent to diabetes. By focusing on 
translational regulation, I uncovered a novel ERK/hnRNPK/JUND axis that is 
activated during metabolic stress. There were several advantages to the 
translation-centric approach used in these studies. First, the translational 
induction of JUND was not accompanied by an increase in mRNA abundance, 
therefore examining the transcriptome would not have identified JUND as a 
stress-responsive factor. Second, assessing translational regulation on a 
genome-wide scale with TRAP-seq allowed me to probe for upstream regulators 
of translation by searching for common features of genes with changes in 
ribosome occupancy. This led to the identification of a poly(C) motif that was 
enriched in 3’UTRs, which implicated the PCBP family members in post-
transcriptional regulation in β cells. 
The initial TRAP screen led me to investigate the role of JUND in β cells. Given 
its previous link to regulating antioxidant genes, I hypothesized that JUND 
induction during metabolic stress was a protective mechanism, and that loss of 
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JUND would exacerbate ROS accumulation. Surprisingly, however, I found the 
opposite effect: depletion of JUND blocked the increase in oxidative stress during 
glucolipotoxicity.  
As a transcription factor, the role of JUND in a particular cell type is completely 
dependent on the cohort of genes it regulates. Consistent with its effect on 
oxidative stress, loss of JUND in β cells led to the downregulation of pro-oxidant, 
rather than anti-oxidant genes. The mechanism underlying this cell type-specific 
role for JUND is likely related to its array of interacting factors. JUND binds to 
DNA as a homo- or hetero-dimer with other members of the Jun transcription 
factor family or with members of the Fos, Atf, and Maf transcription factor 
families, and the composition of these dimers will dictate the DNA binding 
preference and transcriptional effect of JUND (Mechta-Grigoriou et al., 2001). 
Thus, the discrepancy in transcriptional targets between cell types may be 
attributable to the relative expression of JUND binding partners.  
Furthermore, I used RNA-seq to perform an unbiased search for JUND targets, 
which led to the identification of a relatively small cohort of genes, many of which 
have been implicated in ROS production and inflammation. Strikingly, this set of 
genes significantly overlapped with genes upregulated in various models of β cell 
dysfunction, including islets from db/db mice, human islets treated with palmitate, 
and Min6 cells with PDX1 deficiency. This supports a model in which JUND 
regulates genes implicated in β cell dysfunction and suggests my findings may 
be generalizable and not specific to the model of glucolipotoxicity. 
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Lastly, if JUND were playing an antioxidant role in β cells, as has been 
suggested in other cell types, one would predict an exacerbation of stress-
induced cell death with loss of JUND because β cells are particularly sensitive to 
oxidative stress (Lenzen et al., 1996). Instead, I observed that depletion of JUND 
in β cells significantly blunted apoptosis during metabolic stress, consistent with 
the proposed pro-oxidant role for JUND. Collectively, these results significantly 
strengthen the novel finding that JUND has a maladaptive function in β cells by 
promoting oxidative stress. 
I also identified the MEK/ERK signaling pathway as being necessary and 
sufficient to activate the hnRNPK/JUND pathway in β cells. Given the pro-
apoptotic role ascribed to JUND during metabolic stress, I investigated whether 
blocking JUND induction via MEK inhibition would also improve cell viability and 
found a striking reduction in apoptosis during glucolipotoxicity. While this result is 
consistent with the effect of JUND depletion on apoptosis, it is unclear to what 
extent the benefit of MEK inhibition can be attributed to reduced JUND levels. 
Inhibition of the MEK/ERK signaling pathway will have broad effects on the cell, 
therefore it is very likely that other downstream targets also contribute to this 
phenotype. For example, ERK-mediated upregulation of p53 has been found to 
increase levels of pro-apoptotic factors, such as BAX (Cagnol and Chambard, 
2009). 
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Given these pro-oxidant and pro-apoptotic roles for JUND in β cells, I reasoned 
that advancing our mechanistic understanding of JUND induction could provide 
new targets for diabetes therapy. To this end, I utilized publicly available data 
sets of hnRNPK interacting factors to identify candidate cofactors, leading to the 
discovery that the RNA helicase DDX3X is required for efficient JUND 
translation. This factor can impact translation via its ATP-dependent helicase 
activity or by recruiting components of the translation pre-initiation complex (PIC) 
(Marintchev, 2013). Interestingly, there was increased interaction between 
DDX3X and the 18S ribosomal RNA, a component of the PIC, during metabolic 
stress. This indicates that the function of DDX3X is regulated during 
glucolipotoxicity. Further, loss of hnRNPK significantly reduced the interaction 
between DDX3X and 18S. These findings suggest a model in which an hnRNPK-
DDX3X complex increases JUND translation in part via recruitment of the PIC. 
To study translational regulation in the setting of β cell dysfunction, I employed 
the models of PDX1 deficiency and glucolipotoxicity. While my data implicate the 
PCBP family members as translational regulators in both of these models, the 
mechanisms by which the PCBPs impact translation are likely distinct in these 
two scenarios. For example, NKX2-2 exhibited increased translation during 
PDX1 deficiency, but I did not detect any induction of NKX2-2 during 
glucolipotoxicity. Furthermore, I did not observe any change in phosphorylation of 
hnRNPK during PDX1 deficiency, unlike glucolipotoxicity.  
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It is currently unclear how depletion of PDX1 affects the ribosome occupancy of 
the poly(C)-containing mRNAs. One possibility is that PDX1 controls expression 
of a component of the translation machinery that is not required for genes with 
PCBP binding in their 3’UTR. For example, PDX1 deficiency causes a modest 
reduction (~50%) in eIF1AX and eIF1AD, which have been implicated in PIC 
recruitment and start codon selection (Passmore et al., 2007), similar to DDX3X 
(Guenther et al., 2018). Therefore, one interesting possibility is that genes 
regulated by an hnRNPK-DDX3X complex can “escape” translational repression 
caused by reductions in eIF1AX/D. However, PDX1 regulates a very broad set of 
genes in β cells, so there are many possible mechanisms that could explain 
altered translation of the poly(C)-containing genes. Indeed, I have tested a 
number of potential mechanisms based on genes regulated by PDX1 but have 
been unable to establish a connection to the post-transcriptional regulation of 
NKX2-2 or JUND. These mechanisms include: sequestration by a decoy RNA 
(insulin or PDX1 mRNAs), competition with other RBPs (PTB or YBX1), loss of 
eIF4H, and altered recruitment of BRG1 or the long-noncoding RNA NEAT1.  
5.2  Additional screens for translational regulation in β cells 
In the current work, I have used TRAP-seq to study translational regulation in 
Min6 cells with PDX1 deficiency. This approach was successful in that it led to 
the identification of JUND as a translationally regulated gene and suggested a 
role for the PCBP family of RBPs in mediating this post-transcriptional regulation. 
However, there are a number of additional screens one could imagine to further 
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investigate translational regulation in β cells. Given the induction of JUND during 
glucolipotoxicity, it would be interesting to determine how widespread 
translatome remodeling is in this model. Alternatively, TRAP could be performed 
in Min6 cells treated with conditions to invoke particular forms of stress, such as 
thapsigargin/tunicamycin (ER stress) or hydrogen peroxide/nitric oxide 
(oxidative/nitrosative stress). These treatment strategies may be favorable over 
glucolipotoxicity as they would be focused on a particular stress response and 
therefore be potentially less complex. For example, glucolipotoxicity may 
simultaneously invoke a number of pathways in β cells, such as responses to ER 
stress, oxidative stress, and mitochondrial dysfunction. 
Beyond additional TRAP-seq studies, a very exciting extension of this work 
would be to use ribosome profiling (or an adaptation of this method) to globally 
assess start codon usage in β cells. Alternative translation initiation appears to 
be widespread and can increase the diversity of proteins expressed in a cell 
(Ingolia et al., 2011). Furthermore, start codon usage may be altered under 
stress or disease conditions (Kearse and Wilusz, 2017; Sendoel et al., 2017). 
However, mapping of start codon usage to identify alternative initiation sites 
under stress conditions has not been performed in β cells. This is particularly 
intriguing in the context of type 1 diabetes as it has been suggested that 
translation of a non-canonical open reading frame in the insulin mRNA may 
generate an immunogenic peptide contributing to disease onset (Kracht et al., 
2017). Thus, one can imagine the power of this approach to uncover novel 
146	  
	  
mechanisms of translational regulation that may be altered under conditions 
associated with diabetes. 
Another promising extension of my work is the use of TRAP to assess 
translational regulation during stress conditions in vivo, such as high fat diet 
feeding. A mouse has been generated to express the GFP-RPL10A transgene in 
a Cre-driven manner (Liu et al., 2014). Thus, the use of a β cell-specific Cre line 
will allow for the purification of ribosome-bound mRNA specifically from β cells. 
Limiting material may cause this application to be technically challenging, 
however, the continued advancement of sequencing technologies suggest it will 
likely be possible in the near future.  
5.3  Assessment of RBP functions in β cells 
The work presented here includes the first characterization of functional roles for 
the PCBP family members in β cells. Importantly, I came upon this family of 
RBPs through an unbiased search for regulatory motifs in our TRAP screen. 
Using in vitro models, I have implicated the members hnRNPK and PCBP1/2 in 
several aspects of β cell biology, including post-transcriptional control of gene 
expression, maintenance of cell identity, and glucose-stimulated insulin 
secretion. Thus, an important next step will be the use of mouse models to 
genetically delete these factors in vivo, which is ongoing work in the Stoffers’ 
laboratory. To connect phenotypic findings to PCBP function, a number of 
approaches will be required, including CLIP-seq and transcriptome/translatome 
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assessments to identify pertinent target genes. Given the multifunctional nature 
of these RBPs, they may have broad roles in β cells, however, a careful and 
systematic analysis of their function holds great promise to uncover novel 
aspects of β cell biology. 
Furthermore, there is an extensive array of RBPs in the mammalian genome that 
control all aspects RNA processing. However, we are only just beginning to 
understand how this class of proteins may shape critical processes involved in β 
cell biology. Thus, it will be important to undertake studies aimed at uncovering 
novel roles for RBPs in β cells. In this work, I have accomplished this by using a 
de novo motif analysis to narrow our focus on RBPs with specificity for cytosine-
rich sequences. Similarly, new screens for translationally regulated genes could 
also be analyzed to search for enriched regulatory motifs. This bottom-up 
approach will be strengthened by the increasing number of publically available 
data sets to globally define RBP targets by eCLIP (Van Nostrand et al., 2016), 
which will allow for the assessment of gene sets for enrichment of RBP binding, 
not just motif frequency.  
Alternatively, novel roles for RBPs in β cells could be identified by a top-down 
approach, which would start with screening for RBPs with unique characteristics 
in β cells. For example, transcriptomic, proteomic, or phospho-proteomic data 
sets could be mined to identify RBPs with altered abundance or modifications in 
conditions associated with diabetes. Similarly, relative expression could be 
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assessed to identify RBPs with especially high expression levels in β cells 
compared to other cell types. 	  
5.4  Expanding the analysis of JUND function and regulation 
In β cells, JUND regulates a cohort of genes implicated in redox imbalance and 
inflammation, and these genes are commonly dysregulated in models of β cell 
dysfunction. However, the extent to which each of these genes contributes to β 
cell apoptosis is unknown. For example, NOS2, a nitric oxide synthase, has been 
implicated in mediating β cell damage in the context of cytokine treatment 
(Zumsteg et al., 2000). However, nitric oxide may play beneficial roles in β cells 
under certain circumstances by neutralizing other oxidant types (Broniowska et 
al., 2015). Thus, the induction of several pro-oxidant genes by JUND may lead to 
complex downstream effects on redox homeostasis based on the types and 
subcellular locations of the generated oxidants. While we believe it is unlikely that 
the observed pro-apoptotic role for JUND can be entirely ascribed to one 
particular target gene, close scrutiny of these genes may provide new insights 
into redox imbalance during metabolic stress.  
It should also be noted that the oxidative stress assay used in this work 
(CellROX) is not specific to any particular oxidant, but rather detects a range of 
ROS types. This was a useful approach to screen for general oxidative stress 
levels; however, follow-up studies using more specific assays could provide 
better insight into which oxidants are upregulated during glucolipotoxicity in a 
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JUND-dependent manner. For example, dihydroethidium and spin trapping of 
nitrogen dioxide can be used to specifically detect superoxide and nitric oxide 
levels, respectively (Pace and Kalyanaraman, 1993; Zhao et al., 2003). These 
analyses may also shed light on which JUND targets are contributing to oxidative 
stress during glucolipotoxicity. 
Besides its pro-oxidant role, JUND also regulates several pro-inflammatory 
genes with connections to islet inflammation, including Ccl2, Cxcl1, and Cxcl2. 
Interestingly, these genes have been linked to poor outcomes for islet 
transplantation (Citro et al., 2012; Piemonti et al., 2002), suggesting that 
modulation of JUND levels could be a novel approach to advance this clinically 
relevant application. It is unlikely that the induction of these pro-inflammatory 
genes contributed to the phenotypes observed in our in vitro and ex vivo systems 
because their main function involves immune cell recruitment. Nevertheless, we 
cannot rule out the possibility that these genes also have cell-autonomous roles 
in β dysfunction. To better assess the relevance of the pro-inflammatory gene 
signature, however, it will be important to investigate the benefit of JUND 
depletion or MEK inhibition using in vivo islet transplantation models. 
Given its impact on oxidative stress and apoptosis, the role of JUND in β cell 
compensation during insulin resistance should also be studied. This will require 
the generation of a conditional null allele for JUND. Crossing this mouse with a β 
cell-specific Cre line will allow for the in vivo assessment of JUND function in β 
cells. Based on our ex vivo work, we predict that loss of JUND would dampen 
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oxidative stress in β cells during a high fat diet challenge, thus improving insulin 
secretion and blood glucose homeostasis. However, it is possible that JUND also 
regulates insulin secretion independent of its effect on oxidative stress and 
apoptosis. Thus, a careful and thorough characterization of this in vivo model will 
be required to assess the impact of JUND deletion on insulin secretion, oxidative 
stress, cell survival, and proliferation during high fat feeding.  
Similar to JUND depletion, I found a significant improvement in islet cell survival 
during metabolic stress after treatment with the MEK inhibitor trametinib. The 
application of this finding to in vivo models of diabetes is complicated by the fact 
that trametinib treatment has been show to improve insulin resistance (Banks et 
al., 2015). Thus, it will be impossible to discern whether any improvements in 
insulin secretion or β cell viability seen with systemic trametinib administration 
can be attributed to MEK inhibition in β cells or an indirect effect due to reduced 
insulin demand. One approach to more specifically study the role of the 
MEK/ERK signaling pathway in β cells in vivo would be to generate a mouse 
model with a β cell-specific, inducible overexpression of a dominant negative 
form of MEK1, which blocks ERK phosphorylation.  
The connections between the PCBPs and JUND regulation include the presence 
of a poly(C) stretch in the JUND 3’UTR, binding of the PCBP members to the 
JUND mRNA, and loss of PCBPs leading to altered JUND steady-state protein 
levels. Together, these findings suggest that the post-transcriptional regulation of 
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JUND is directly mediated by the PCBPs via 3’UTR binding. To further support 
this model, however, it would be pertinent to show that deletion of the JUND 
poly(C) motif impairs its post-transcriptional regulation. A common approach to 
address this question is to generate a reporter gene flanked by the JUND UTRs 
containing deletions of putative regulatory elements, including the poly(C) motif. 
Unfortunately, I have been unable to develop a model system to recapitulate the 
induction of JUND during glucolipotoxicity despite many attempts, thus I could 
not confidently assess the functionality of the poly(C) motif. Alternatively, genome 
editing approaches could be used to delete the cytosine-rich sequence element 
in the endogenous gene. It is unclear whether this would be feasible in Min6 cells 
as it would require single cell cloning. On the other hand, a mouse model with 
tissue-specific and inducible deletion of the JUND poly(C) motif could be used to 
study whether loss of this sequence element abrogates JUND induction in 
isolated islets treated with glucolipotoxicity. If so, it would be interesting to see if 
this deletion also impacts β cell viability during in vivo stress conditions, such as 
high fat feeding. 
Lastly, I have established that JUND induction during metabolic stress is a 
conserved process using isolated mouse and human islets. To extend these 
findings to the pathogenesis of T2D in humans, it will be critical to evaluate JUND 
levels in pancreatic tissue samples from diabetic patients. This analysis is 
typically performed using immunofluorescence staining of pancreatic sections 
from deceased organ donors. Our ability to perform this experiment is currently 
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limited by the lack of an antibody to confidently detect JUND levels by staining. 
Instead, we have relied on Western blot analyses to assess JUND abundance, 
including for isolated islets from db/db mice. Similarly, we could compare JUND 
levels in isolated islets from diabetic and non-diabetic human organ donors, 
however, it is possible that the culturing period after islet isolation would provide 
time for JUND levels to normalize between groups. Thus, it will be advisable to 
optimize staining conditions for additional antibodies to determine if JUND levels 
are altered in islets from diabetic individuals.   
5.5  Translational regulation mediated by an hnRNPK-DDX3X complex 
To expand our understanding of the factors regulating JUND translation in an 
hnRNPK-dependent manner, I searched the hnRNPK interactome using publicly 
available mass spectrometry data sets. Consistent with its highly multifunctional 
nature, hnRNPK has a broad array of binding partners (Mikula et al., 2015). To 
narrow my search, I capitalized on the fact that JUND is known to have a highly 
structured 5’UTR that requires helicase activity for efficient translation (Hartman 
et al., 2006), leading me to screen three helicase genes. Of these, I found that 
only DDX3X was required for efficient translation of JUND in β cells. I propose a 
model in which hnRNPK and DDX3X form a complex that recruits the translation 
pre-initiation complex (PIC) to the JUND mRNA. Further experimentation will be 
required to clarify several mechanistic details of this model. 
First, it is currently unclear whether the hnRNPK-DDX3X complex regulates 
translation in a cap-dependent manner. Several studies, along with my own data, 
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indicate that there is a global suppression of translation in β cells during 
glucolipotoxicity (Hatanaka et al., 2014). This is likely attributed both to the 
phosphorylation of eIF2α and the induction of 4E-BP1 levels, which sequesters 
eIF4E and reduces cap-dependent translation (Yamaguchi et al., 2008). Thus, 
JUND may “escape” translational suppression during glucolipotoxicity via cap-
independent translation mediated by the hnRNPK-DDX3X complex. The relative 
requirement for the 5’ cap in translation initiation is often assessed by inserting 
5’UTR sequences into a bicistronic reporter assay. Given my challenges to 
model JUND translation using reporter systems, however, it is unclear whether 
this approach will be useful to assess cap-independent mechanisms.  
One difference between the effect of hnRNPK and DDX3X on JUND translation 
is that hnRNPK is only required for the induction of JUND during metabolic stress 
but does not impact JUND regulation under baseline conditions. On the other 
hand, loss of DDX3X impairs JUND translation both under baseline and stress 
conditions. One possible explanation for this discrepancy is that DDX3X can 
interact with an additional factor or factors under baseline conditions that can 
functionally substitute for hnRNPK, and this unknown factor may be lost or 
inactivated under stress conditions. For example, DDX3X interacts with PABP 
(Soto-Rifo et al., 2012), which binds to the 3’UTR of the JUND mRNA via the 
polyA tail. Thus, under baseline conditions, PABP and hnRNPK may play 
redundant roles in JUND translation via their interactions with DDX3X. During 
stress conditions, however, PABP may be inactivated or reduced, leading to the 
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dependency on hnRNPK for efficient JUND translation. PABP can be regulated 
by its expression level, proteolytic cleavage, post-translational modification, and 
the expression of inhibitory factors, such as PAIP2 (McKinney et al., 2013; Walsh 
et al., 2013). However, it is currently unknown if any change in PABP expression 
or function occurs during glucolipotoxicity.  
While I chose DDX3X as a candidate based on its known helicase function, it is 
unclear whether this enzymatic activity of DDX3X is required for JUND 
translation. Indeed, some DEAD-box proteins regulate translation of specific 
mRNAs via recruitment of the PIC, which is independent of their helicase activity 
(Marintchev, 2013). Thus, it will be worthwhile to mutate the functional domains 
of DDX3X to further examine how this protein regulates JUND translation. 
Additionally, DDX3X has been implicated in the proper selection of translation 
initiation sites (Guenther et al., 2018). Interestingly, I have found that loss of 
DDX3X in Min6 cells leads to the appearance of an additional faint band for 
JUND on western blot, which may represent translation from an alternative start 
codon. To expand on this observation, ribosome profiling could be used to 
globally map translation initiation sites in control and DDX3X-depleted β cells. 
Additionally, the precise mechanism by which hnRNPK may impact DDX3X 
function deserves closer examination. I considered the possibility that hnRNPK 
recruits DDX3X to the JUND mRNA in a stress-dependent manner, but I saw no 
change in the hnRNPK-DDX3X interaction during glucolipotoxicity by co-
immunoprecipitation experiments. Instead, I found that DDX3X interacts with the 
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18S ribosomal RNA, a component of the PIC, in an hnRNPK- and stress-
dependent manner. However, it is unclear how hnRNPK regulates the interaction 
between DDX3X and the PIC. To better understand the components of this 
complex and how they change under metabolic stress, it would be informative to 
perform mass spectrometry on hnRNPK- and DDX3X-interacting factors under 
control and glucolipotoxic conditions.  
I have implicated DDX3X in regulating JUND translation in β cells, but whether 
this RNA helicase impacts β cell function or viability is unknown. DDX3X likely 
regulates a range of targets in β cells, thus it is unclear whether loss of this factor 
will have any overlapping phenotypes with those we have observed for JUND 
depletion. Given its links to cell cycle progression, apoptosis, and innate 
immunity in other cell types (Ariumi, 2014), however, a broader examination of 
DDX3X function in β cells is warranted. Anecdotally, CRISPR-mediated depletion 
of DDX3X in Min6 cells leads to a significant reduction in cell number over time. 
This may be attributable to a reduction in cell proliferation as DDX3X has 
previously been shown to enhance translation of the mRNA encoding cyclin E1 
(Lai et al., 2010). To better define the role of DDX3X in β cells, loss-of-function 
studies should be performed in primary islets or in vivo to assess the impact on 
cell survival, proliferation, and insulin secretion. Furthermore, a broad 
examination of genes regulated by DDX3X should be carried out using TRAP-
seq or ribosome profiling to provide mechanistic insight into how this RNA 
helicase impacts β cell biology.  
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